CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: 8-Br-cAMP
Accession: CHEBI:64211
browse the term
Definition: A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic AMP bearing an additional bromo substituent at position 8 on the adenine ring. An activator of cyclic AMP-dependent protein kinase, but resistant to degradation by cyclic AMP phosphodiesterase.
Synonyms: exact_synonym: 8-bromoadenosine 3',5'-(hydrogen phosphate)
related_synonym: (4aR,6R,7R,7aS)-6-(6-amino-8-bromo-9H-purin-9-yl)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinine-2,7-diol 2-oxide; 8-Bromo-cAMP; 8-bromo cyclic adenosine monophosphate; 8-bromo-cyclic 3',5'-AMP; 8-bromo-cyclic AMP; 8-bromoadenosine 3',5'-cyclic monophosphate; 8-bromoadenosine 3',5'-monophosphate; 8-bromoadenosine cyclic 3',5'-phosphate; BCAMP; Formula=C10H11BrN5O6P; InChI=1S/C10H11BrN5O6P/c11-10-15-4-7(12)13-2-14-8(4)16(10)9-5(17)6-3(21-9)1-20-23(18,19)22-6/h2-3,5-6,9,17H,1H2,(H,18,19)(H2,12,13,14)/t3-,5-,6-,9-/m1/s1; InChIKey=DVKQVRZMKBDMDH-UUOKFMHZSA-N; SMILES=Nc1ncnc2n([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)c(Br)nc12
alt_id: CHEBI:145729; CHEBI:84608
xref: CAS:23583-48-4
xref_mesh: MESH:D015124
xref: PMID:10543424; PMID:10708595; PMID:11906532; PMID:12216111; PMID:1320750; PMID:1367038; PMID:15121638; PMID:15169861; PMID:15225757; PMID:15717604; PMID:16134057; PMID:16214133; PMID:16425431; PMID:17140607; PMID:18239846; PMID:1849229; PMID:19121393; PMID:1982459; PMID:19833172; PMID:21120637; PMID:21284604; PMID:2240104; PMID:2413029; PMID:24493289; PMID:24518258; PMID:24605759; PMID:2478258; PMID:2560108; PMID:2581952; PMID:2744214; PMID:29887570; PMID:29997437; PMID:3032362; PMID:30374127; PMID:3094467; PMID:6128338; PMID:6196214; PMID:6327153; PMID:6367831; PMID:7996791; PMID:8095554; PMID:8107042; PMID:8394699; PMID:8699249; PMID:8730238; PMID:8841091; PMID:9042334; PMID:9327456; PMID:9713380; Reaxys:591930; Wikipedia:8-Bromoadenosine_3'\,5'-cyclic_monophosphate
G
ABCA1
ATP binding cassette subfamily A member 1
increases expression
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ABCA1 protein
CTD
PMID:17478430
NCBI chr 9:104,781,006...104,928,155
Ensembl chr 9:104,781,006...104,928,155
G
ABCB11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Ethinyl Estradiol results in decreased expression of ABCB11 mRNA]
CTD
PMID:27743861
NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABCC1 mRNA
CTD
PMID:22079614
NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
G
ABCC2
ATP binding cassette subfamily C member 2
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Ethinyl Estradiol results in decreased expression of ABCC2 mRNA]
CTD
PMID:27743861
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCD2
ATP binding cassette subfamily D member 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABCD2 mRNA
CTD
PMID:22079614
NCBI chr12:39,531,025...39,619,803
Ensembl chr12:39,550,033...39,619,803
G
ABCG1
ATP binding cassette subfamily G member 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABCG1 mRNA
CTD
PMID:22079614
NCBI chr21:42,199,689...42,297,244
Ensembl chr21:42,199,689...42,297,244
G
ABCG2
ATP binding cassette subfamily G member 2 (JR blood group)
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [anandamide results in decreased expression of ABCG2 mRNA]
CTD
PMID:30610963
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
G
ABLIM1
actin binding LIM protein 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABLIM1 mRNA
CTD
PMID:22079614
NCBI chr10:114,431,110...114,801,373
Ensembl chr10:114,431,112...114,768,061
G
ABLIM2
actin binding LIM protein family member 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ABLIM2 mRNA
CTD
PMID:22079614
NCBI chr 4:7,965,327...8,158,813
Ensembl chr 4:7,965,310...8,158,832
G
ACAT2
acetyl-CoA acetyltransferase 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ACAT2 mRNA
CTD
PMID:22079614
NCBI chr 6:159,762,045...159,779,112
Ensembl chr 6:159,762,045...159,779,112
G
ACE2
angiotensin converting enzyme 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ACE2 mRNA
CTD
PMID:22079614
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
ACP3
acid phosphatase 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ACP3 mRNA
CTD
PMID:22079614
NCBI chr 3:132,317,407...132,368,302
Ensembl chr 3:132,317,369...132,368,302
G
ADAMTS6
ADAM metallopeptidase with thrombospondin type 1 motif 6
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ADAMTS6 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 5:65,148,738...65,481,920
Ensembl chr 5:65,148,738...65,481,920
G
ADAMTS8
ADAM metallopeptidase with thrombospondin type 1 motif 8
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADAMTS8 mRNA
CTD
PMID:22079614
NCBI chr11:130,404,923...130,428,609
Ensembl chr11:130,404,923...130,428,609
G
ADCY7
adenylate cyclase 7
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADCY7 mRNA
CTD
PMID:22079614
NCBI chr16:50,244,699...50,318,135
Ensembl chr16:50,246,137...50,318,135
G
ADGRD1
adhesion G protein-coupled receptor D1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ADGRD1 mRNA
CTD
PMID:22079614
NCBI chr12:130,953,907...131,141,469
Ensembl chr12:130,953,907...131,141,469
G
ADGRF5
adhesion G protein-coupled receptor F5
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ADGRF5 mRNA
CTD
PMID:16997883
NCBI chr 6:46,852,522...46,954,939
Ensembl chr 6:46,852,522...46,954,943
G
ADGRG1
adhesion G protein-coupled receptor G1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ADGRG1 mRNA
CTD
PMID:22079614
NCBI chr16:57,619,738...57,665,567
Ensembl chr16:57,610,652...57,665,580
G
ADGRG2
adhesion G protein-coupled receptor G2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADGRG2 mRNA
CTD
PMID:22079614
NCBI chr X:18,989,307...19,122,956
Ensembl chr X:18,989,307...19,122,637
G
ADRA2A
adrenoceptor alpha 2A
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADRA2A mRNA
CTD
PMID:22079614
NCBI chr10:111,077,029...111,080,907
Ensembl chr10:111,077,029...111,080,907
G
AGR2
anterior gradient 2, protein disulphide isomerase family member
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AGR2 mRNA
CTD
PMID:16997883
NCBI chr 7:16,791,811...16,804,999
Ensembl chr 7:16,791,811...16,833,433
G
AGT
angiotensinogen
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AGT mRNA
CTD
PMID:22079614
NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
G
AGTR1
angiotensin II receptor type 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AGTR1 mRNA
CTD
PMID:22079614
NCBI chr 3:148,697,903...148,743,003
Ensembl chr 3:148,697,784...148,743,008
G
AHR
aryl hydrocarbon receptor
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of AHR mRNA
CTD
PMID:22079614
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
AIFM1
apoptosis inducing factor mitochondria associated 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of AIFM1 mRNA
CTD
PMID:22079614
NCBI chr X:130,129,362...130,165,841
Ensembl chr X:130,124,666...130,165,879
G
AKAP7
A-kinase anchoring protein 7
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of AKAP7 mRNA
CTD
PMID:16997883
NCBI chr 6:131,125,627...131,283,532
Ensembl chr 6:131,135,467...131,283,535
G
AKAP9
A-kinase anchoring protein 9
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AKAP9 mRNA
CTD
PMID:22079614
NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673
G
AKT1
AKT serine/threonine kinase 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AKT1 mRNA
CTD
PMID:22079614
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,759
G
ALB
albumin
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ALB mRNA
CTD
PMID:22079614
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
ALDH1A1
aldehyde dehydrogenase 1 family member A1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ALDH1A1 mRNA
CTD
PMID:22079614
NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
G
ANGPT1
angiopoietin 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ANGPT1 mRNA
CTD
PMID:16997883
NCBI chr 8:107,249,482...107,497,918
Ensembl chr 8:107,249,482...107,498,055
G
ANGPTL1
angiopoietin like 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ANGPTL1 mRNA
CTD
PMID:22079614
NCBI chr 1:178,849,535...178,871,077
Ensembl chr 1:178,849,535...178,871,077
G
ANKH
ANKH inorganic pyrophosphate transport regulator
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ANKH mRNA
CTD
PMID:20147733
NCBI chr 5:14,704,800...14,871,778
Ensembl chr 5:14,704,800...14,871,778
G
ANKRD20A2P
ankyrin repeat domain 20 family member A2, pseudogene
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ANKRD20A2P mRNA
CTD
PMID:22079614
NCBI chr 9:40,222,102...40,282,358
Ensembl chr 9:40,223,397...40,292,345
G
ANXA8
annexin A8
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of ANXA8 mRNA
CTD
PMID:16997883
NCBI chr10:47,467,993...47,991,796
Ensembl chr10:47,460,162...47,484,158
G
AOPEP
aminopeptidase O (putative)
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AOPEP mRNA
CTD
PMID:22079614
NCBI chr 9:94,726,699...95,150,224
Ensembl chr 9:94,726,604...95,151,793
G
APAF1
apoptotic peptidase activating factor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of APAF1 mRNA
CTD
PMID:22079614
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,149...98,735,433
G
APBB1IP
amyloid beta precursor protein binding family B member 1 interacting protein
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of APBB1IP mRNA
CTD
PMID:22079614
NCBI chr10:26,438,341...26,567,803
Ensembl chr10:26,438,341...26,567,803
G
APC
APC regulator of WNT signaling pathway
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of APC mRNA
CTD
PMID:22079614
NCBI chr 5:112,707,498...112,846,239
Ensembl chr 5:112,707,518...112,846,239
G
APCDD1
APC down-regulated 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of APCDD1 mRNA
CTD
PMID:22079614
NCBI chr18:10,454,635...10,489,949
Ensembl chr18:10,454,635...10,489,949
G
AR
androgen receptor
decreases expression multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of AR mRNA [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of AR mRNA; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of AR mRNA]
CTD
PMID:18467523 PMID:22079614
NCBI chr X:67,544,021...67,730,619
Ensembl chr X:67,544,021...67,730,619
G
AREG
amphiregulin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of AREG mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
G
ARHGEF2
Rho/Rac guanine nucleotide exchange factor 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ARHGEF2 mRNA
CTD
PMID:22079614
NCBI chr 1:155,946,854...155,979,617
Ensembl chr 1:155,946,851...156,007,070
G
ARHGEF4
Rho guanine nucleotide exchange factor 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ARHGEF4 mRNA
CTD
PMID:22079614
NCBI chr 2:130,836,914...131,047,253
Ensembl chr 2:130,836,914...131,047,263
G
ARID5B
AT-rich interaction domain 5B
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ARID5B mRNA
CTD
PMID:22079614
NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
G
ARMCX3
armadillo repeat containing X-linked 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ARMCX3 mRNA
CTD
PMID:22079614
NCBI chr X:101,623,151...101,627,843
Ensembl chr X:101,622,797...101,627,843
G
ARMCX4
armadillo repeat containing X-linked 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ARMCX4 mRNA
CTD
PMID:22079614
NCBI chr X:101,418,278...101,535,988
Ensembl chr X:101,418,287...101,533,459
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ASNS mRNA
CTD
PMID:22079614
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
ATP4A
ATPase H+/K+ transporting subunit alpha
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ATP4A mRNA
CTD
PMID:22079614
NCBI chr19:35,550,031...35,563,658
Ensembl chr19:35,550,031...35,563,658
G
AVPI1
arginine vasopressin induced 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of AVPI1 mRNA
CTD
PMID:22079614
NCBI chr10:97,677,424...97,687,241
Ensembl chr10:97,677,424...97,687,241
G
B4GALNT3
beta-1,4-N-acetyl-galactosaminyltransferase 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of B4GALNT3 mRNA
CTD
PMID:22079614
NCBI chr12:459,939...563,509
Ensembl chr12:459,939...563,509
G
BANK1
B cell scaffold protein with ankyrin repeats 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BANK1 mRNA
CTD
PMID:22079614
NCBI chr 4:101,790,730...102,074,812
Ensembl chr 4:101,411,286...102,074,812
G
BAX
BCL2 associated X, apoptosis regulator
increases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BAX [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BAX protein
CTD
PMID:11802967 PMID:16709600
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCAT1
branched chain amino acid transaminase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BCAT1 mRNA
CTD
PMID:22079614
NCBI chr12:24,810,024...24,949,340
Ensembl chr12:24,810,024...24,949,101
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BCL2
CTD
PMID:11802967
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BCL2L11
BCL2 like 11
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of BCL2L11 protein
CTD
PMID:16709600
NCBI chr 2:111,120,914...111,168,445
Ensembl chr 2:111,119,378...111,168,444
G
BDKRB1
bradykinin receptor B1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BDKRB1 mRNA
CTD
PMID:20147733
NCBI chr14:96,256,210...96,264,763
Ensembl chr14:96,256,210...96,268,967
G
BDKRB2
bradykinin receptor B2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BDKRB2 mRNA
CTD
PMID:20147733
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BMP4
bone morphogenetic protein 4
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BMP4 mRNA
CTD
PMID:22079614
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
BMP6
bone morphogenetic protein 6
decreases expression increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BMP6 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BMP6 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
G
BRINP1
BMP/retinoic acid inducible neural specific 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BRINP1 mRNA
CTD
PMID:20147733
NCBI chr 9:119,166,629...119,369,435
Ensembl chr 9:119,153,458...119,369,435
G
BTBD9
BTB domain containing 9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of BTBD9 mRNA
CTD
PMID:22079614
NCBI chr 6:38,168,451...38,639,929
Ensembl chr 6:38,168,451...38,640,148
G
CABLES1
Cdk5 and Abl enzyme substrate 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CABLES1 mRNA
CTD
PMID:22079614
NCBI chr18:23,134,564...23,260,470
Ensembl chr18:23,134,564...23,260,470
G
CABP7
calcium binding protein 7
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CABP7 mRNA
CTD
PMID:22079614
NCBI chr22:29,720,003...29,731,833
Ensembl chr22:29,720,003...29,731,833
G
CADM1
cell adhesion molecule 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CADM1 mRNA
CTD
PMID:22079614
NCBI chr11:115,169,236...115,504,415
Ensembl chr11:115,169,218...115,504,957
G
CADM2
cell adhesion molecule 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CADM2 mRNA
CTD
PMID:22079614
NCBI chr 3:84,958,989...86,074,429
Ensembl chr 3:84,958,989...86,074,429
G
CALN1
calneuron 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CALN1 mRNA
CTD
PMID:22079614
NCBI chr 7:71,779,491...72,504,279
Ensembl chr 7:71,779,491...72,447,151
G
CALR
calreticulin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CALR mRNA
CTD
PMID:22079614
NCBI chr19:12,938,609...12,944,489
Ensembl chr19:12,938,578...12,944,489
G
CAMK2N1
calcium/calmodulin dependent protein kinase II inhibitor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CAMK2N1 mRNA
CTD
PMID:22079614
NCBI chr 1:20,482,391...20,486,210
Ensembl chr 1:20,482,391...20,486,210
G
CAPN15
calpain 15
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CAPN15 mRNA
CTD
PMID:22079614
NCBI chr16:527,712...554,636
Ensembl chr16:527,712...554,636
G
CAPN2
calpain 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CAPN2 mRNA
CTD
PMID:22079614
NCBI chr 1:223,701,597...223,776,018
Ensembl chr 1:223,701,593...223,776,018
G
CAPN6
calpain 6
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CAPN6 mRNA
CTD
PMID:22079614
NCBI chr X:111,245,099...111,270,483
Ensembl chr X:111,245,099...111,270,483
G
CARD14
caspase recruitment domain family member 14
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CARD14 mRNA
CTD
PMID:22079614
NCBI chr17:80,170,030...80,209,331
Ensembl chr17:80,169,992...80,216,073
G
CARS1
cysteinyl-tRNA synthetase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CARS1 mRNA
CTD
PMID:22079614
NCBI chr11:3,000,929...3,057,423
Ensembl chr11:3,000,922...3,057,613
G
CASP3
caspase 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CASP3 mRNA
CTD
PMID:22079614
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP9
caspase 9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CASP9 mRNA
CTD
PMID:22079614
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CAT
catalase
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CAT mRNA
CTD
PMID:16709600
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CBR4
carbonyl reductase 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CBR4 mRNA
CTD
PMID:22079614
NCBI chr 4:168,894,486...169,010,255
Ensembl chr 4:168,863,770...169,010,275
G
CCDC170
coiled-coil domain containing 170
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCDC170 mRNA
CTD
PMID:22079614
NCBI chr 6:151,494,017...151,621,193
Ensembl chr 6:151,494,017...151,621,193
G
CCDC3
coiled-coil domain containing 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CCDC3 mRNA
CTD
PMID:22079614
NCBI chr10:12,896,625...13,099,989
Ensembl chr10:12,896,625...13,099,652
G
CCDC80
coiled-coil domain containing 80
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCDC80 mRNA
CTD
PMID:22079614
NCBI chr 3:112,596,797...112,641,143
Ensembl chr 3:112,596,797...112,649,530
G
CCL2
C-C motif chemokine ligand 2
multiple interactions increases expression
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]]; [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CCL2 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CCL2 protein
CTD
PMID:11230753 PMID:16997883 PMID:20940016
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL5
C-C motif chemokine ligand 5
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of CCL5 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]
CTD
PMID:10495789
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CCN3
cellular communication network factor 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCN3 mRNA
CTD
PMID:22079614
NCBI chr 8:119,416,446...119,424,434
Ensembl chr 8:119,416,446...119,424,434
G
CCN6
cellular communication network factor 6
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCN6 mRNA
CTD
PMID:22079614
NCBI chr 6:112,052,813...112,069,686
Ensembl chr 6:112,054,075...112,069,686
G
CCNA1
cyclin A1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CCNA1 mRNA
CTD
PMID:22079614
NCBI chr13:36,431,517...36,442,870
Ensembl chr13:36,431,520...36,442,870
G
CCND2
cyclin D2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CCND2 mRNA
CTD
PMID:22079614
NCBI chr12:4,273,762...4,305,353
Ensembl chr12:4,269,771...4,305,353
G
CD244
CD244 molecule
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CD244 mRNA
CTD
PMID:22079614
NCBI chr 1:160,830,160...160,862,887
Ensembl chr 1:160,830,160...160,862,887
G
CD74
CD74 molecule
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CD74 mRNA
CTD
PMID:22079614
NCBI chr 5:150,401,639...150,412,910
Ensembl chr 5:150,401,637...150,412,969
G
CD9
CD9 molecule
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CD9 mRNA
CTD
PMID:22079614
NCBI chr12:6,199,946...6,238,266
Ensembl chr12:6,199,715...6,238,271
G
CDC42
cell division cycle 42
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [CRH protein inhibits the reaction [CGB3 protein results in increased chemical synthesis of Testosterone]]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [CGB3 protein results in increased chemical synthesis of Testosterone]]
CTD
PMID:2153673
NCBI chr 1:22,052,709...22,101,360
Ensembl chr 1:22,052,627...22,101,360
G
CDH1
cadherin 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDH1 protein
CTD
PMID:32028606
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CDH22
cadherin 22
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDH22 mRNA
CTD
PMID:22079614
NCBI chr20:46,173,739...46,308,498
Ensembl chr20:46,173,739...46,308,498
G
CDH4
cadherin 4
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDH4 mRNA
CTD
PMID:22079614
NCBI chr20:61,252,261...61,940,617
Ensembl chr20:61,252,261...61,940,617
G
CDH6
cadherin 6
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CDH6 mRNA
CTD
PMID:22079614
NCBI chr 5:31,193,686...31,329,146
Ensembl chr 5:31,193,686...31,329,146
G
CDK2
cyclin dependent kinase 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDK2 mRNA
CTD
PMID:22079614
NCBI chr12:55,966,830...55,972,789
Ensembl chr12:55,966,781...55,972,789
G
CDKN1A
cyclin dependent kinase inhibitor 1A
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDKN1A mRNA
CTD
PMID:22079614
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CDON
cell adhesion associated, oncogene regulated
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CDON mRNA
CTD
PMID:20147733
NCBI chr11:125,956,821...126,063,352
Ensembl chr11:125,955,796...126,063,335
G
CDX1
caudal type homeobox 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CDX1 mRNA
CTD
PMID:22079614
NCBI chr 5:150,166,778...150,184,558
Ensembl chr 5:150,166,778...150,184,558
G
CEACAM6
CEA cell adhesion molecule 6
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEACAM6 mRNA
CTD
PMID:16997883
NCBI chr19:41,755,530...41,772,211
Ensembl chr19:41,750,977...41,772,211
G
CEBPG
CCAAT enhancer binding protein gamma
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CEBPG mRNA
CTD
PMID:22079614
NCBI chr19:33,373,709...33,382,686
Ensembl chr19:33,373,685...33,382,686
G
CFLAR
CASP8 and FADD like apoptosis regulator
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CFLAR protein alternative form
CTD
PMID:16709600
NCBI chr 2:201,116,164...201,176,687
Ensembl chr 2:201,116,154...201,176,687
G
CGA
glycoprotein hormones, alpha polypeptide
increases expression
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CGA mRNA
CTD
PMID:8404651 PMID:21467749 PMID:22079614
NCBI chr 6:87,085,498...87,095,106
Ensembl chr 6:87,085,498...87,095,106
G
CGN
cingulin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CGN mRNA
CTD
PMID:22079614
NCBI chr 1:151,510,170...151,538,692
Ensembl chr 1:151,510,510...151,538,692
G
CHN1
chimerin 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CHN1 mRNA
CTD
PMID:22079614
NCBI chr 2:174,798,809...175,005,381
Ensembl chr 2:174,798,809...175,005,381
G
CHP1
calcineurin like EF-hand protein 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CHP1 mRNA
CTD
PMID:22079614
NCBI chr15:41,231,268...41,281,887
Ensembl chr15:41,230,839...41,281,887
G
CIDEA
cell death inducing DFFA like effector a
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CIDEA mRNA
CTD
PMID:22079614
NCBI chr18:12,254,361...12,277,595
Ensembl chr18:12,254,361...12,277,595
G
CIDEC
cell death inducing DFFA like effector c
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CIDEC protein
CTD
PMID:21097823
NCBI chr 3:9,866,710...9,880,253
Ensembl chr 3:9,866,711...9,880,255
G
CKMT2
creatine kinase, mitochondrial 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CKMT2 mRNA
CTD
PMID:22079614
NCBI chr 5:81,233,322...81,266,398
Ensembl chr 5:81,233,320...81,266,398
G
CLDN1
claudin 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CLDN1 mRNA
CTD
PMID:22079614
NCBI chr 3:190,305,707...190,322,446
Ensembl chr 3:190,305,707...190,322,446
G
CLDN5
claudin 5
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLDN5 mRNA
CTD
PMID:20711499
NCBI chr22:19,523,024...19,525,337
Ensembl chr22:19,523,024...19,527,545
G
CLGN
calmegin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLGN mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 4:140,388,453...140,427,648
Ensembl chr 4:140,388,453...140,427,661
G
CLIC3
chloride intracellular channel 3
multiple interactions increases expression
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CLIC3 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CLIC3 mRNA
CTD
PMID:16997883 PMID:22079614
NCBI chr 9:136,994,608...136,996,568
Ensembl chr 9:136,994,608...136,996,568
G
CMKLR1
chemerin chemokine-like receptor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CMKLR1 mRNA
CTD
PMID:20147733
NCBI chr12:108,288,046...108,339,311
Ensembl chr12:108,288,044...108,339,317
G
CNIH3
cornichon family AMPA receptor auxiliary protein 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CNIH3 mRNA
CTD
PMID:22079614
NCBI chr 1:224,434,640...224,740,554
Ensembl chr 1:224,434,660...224,740,554
G
CNR1
cannabinoid receptor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CNR1 mRNA
CTD
PMID:22079614
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
G
COL15A1
collagen type XV alpha 1 chain
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL15A1 mRNA
CTD
PMID:16997883
NCBI chr 9:98,943,907...99,070,787
Ensembl chr 9:98,943,179...99,070,787
G
COL4A4
collagen type IV alpha 4 chain
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of COL4A4 mRNA
CTD
PMID:22079614
NCBI chr 2:226,967,360...227,164,488
Ensembl chr 2:227,002,714...227,164,453
G
COL4A6
collagen type IV alpha 6 chain
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL4A6 mRNA
CTD
PMID:16997883
NCBI chr X:108,155,614...108,439,458
Ensembl chr X:108,155,607...108,439,497
G
COL6A3
collagen type VI alpha 3 chain
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of COL6A3 mRNA
CTD
PMID:22079614
NCBI chr 2:237,324,018...237,414,164
Ensembl chr 2:237,324,003...237,414,328
G
COL7A1
collagen type VII alpha 1 chain
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of COL7A1 mRNA
CTD
PMID:16997883
NCBI chr 3:48,564,073...48,595,329
Ensembl chr 3:48,564,073...48,595,329
G
COLEC12
collectin subfamily member 12
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of COLEC12 mRNA
CTD
PMID:22079614
NCBI chr18:316,737...500,701
Ensembl chr18:316,737...500,722
G
CORO2A
coronin 2A
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CORO2A mRNA
CTD
PMID:22079614
NCBI chr 9:98,120,975...98,192,637
Ensembl chr 9:98,120,975...98,192,637
G
CPM
carboxypeptidase M
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CPM mRNA
CTD
PMID:22079614
NCBI chr12:68,842,197...68,963,469
Ensembl chr12:68,842,197...68,971,570
G
CPO
carboxypeptidase O
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CPO mRNA
CTD
PMID:22079614
NCBI chr 2:206,939,518...206,969,474
Ensembl chr 2:206,939,518...206,969,474
G
CRADD
CASP2 and RIPK1 domain containing adaptor with death domain
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CRADD mRNA
CTD
PMID:22079614
NCBI chr12:93,677,375...93,894,840
Ensembl chr12:93,677,375...93,894,840
G
CREB1
cAMP responsive element binding protein 1
multiple interactions
ISO
[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of CREB1 protein
CTD
PMID:18467523
NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
G
CRH
corticotropin releasing hormone
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [CRH protein inhibits the reaction [CGB3 protein results in increased chemical synthesis of Testosterone]]
CTD
PMID:2153673
NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
G
CRHBP
corticotropin releasing hormone binding protein
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CRHBP mRNA
CTD
PMID:22079614
NCBI chr 5:76,953,045...76,981,159
Ensembl chr 5:76,953,045...76,981,158
G
CST6
cystatin E/M
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of CST6 mRNA
CTD
PMID:16997883
NCBI chr11:66,012,008...66,013,505
Ensembl chr11:66,012,008...66,013,505
G
CTAGE1
cutaneous T cell lymphoma-associated antigen 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CTAGE1 mRNA
CTD
PMID:22079614
NCBI chr18:22,413,599...22,417,915
Ensembl chr18:22,413,599...22,417,915
G
CTNNA2
catenin alpha 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CTNNA2 mRNA
CTD
PMID:22079614
NCBI chr 2:79,185,377...80,648,780
Ensembl chr 2:79,185,231...80,648,861
G
CTTNBP2
cortactin binding protein 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CTTNBP2 mRNA
CTD
PMID:22079614
NCBI chr 7:117,710,651...117,873,441
Ensembl chr 7:117,710,651...117,874,139
G
CUX2
cut like homeobox 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CUX2 mRNA
CTD
PMID:22079614
NCBI chr12:111,034,165...111,350,554
Ensembl chr12:111,034,165...111,350,554
G
CX3CL1
C-X3-C motif chemokine ligand 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CX3CL1 mRNA
CTD
PMID:22079614
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CXCL10
C-X-C motif chemokine ligand 10
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL10 mRNA
CTD
PMID:22079614
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL12
C-X-C motif chemokine ligand 12
decreases expression increases expression
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CXCL12 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL12 mRNA
CTD
PMID:20711499 PMID:22079614
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions increases expression
EXP
daidzein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL8 mRNA]; Estradiol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL8 mRNA]; Genistein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL8 mRNA]
CTD
PMID:21056929 PMID:22079614
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYCS
cytochrome c, somatic
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYCS mRNA
CTD
PMID:22079614
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
G
CYP11A1
cytochrome P450 family 11 subfamily A member 1
multiple interactions increases expression increases activity
ISO EXP
2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein]]; [NR5A1 protein co-treated with 20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11A1 mRNA; Hydrocarbons, Chlorinated inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]]; Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]; Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 protein bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP11A1 protein 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP11A1 protein]
CTD
PMID:20147733 PMID:21126571 PMID:21610156 PMID:21664964 PMID:21726595 PMID:22546480 PMID:24014645 PMID:24328340 PMID:24740604 PMID:34896276 More...
NCBI chr15:74,337,762...74,367,646
Ensembl chr15:74,337,759...74,367,646
G
CYP11B1
cytochrome P450 family 11 subfamily B member 1
multiple interactions increases expression
EXP
bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11B1 mRNA]; Mitotane affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11B1 mRNA]
CTD
PMID:22079614 PMID:22172629 PMID:22546480 PMID:34896276
NCBI chr 8:142,872,357...142,879,825
Ensembl chr 8:142,872,356...142,879,846
G
CYP11B2
cytochrome P450 family 11 subfamily B member 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11B2 mRNA
CTD
PMID:22079614 PMID:34896276
NCBI chr 8:142,910,559...142,917,843
Ensembl chr 8:142,910,559...142,917,843
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
multiple interactions increases expression
EXP ISO
[4-nitro-3-phenylphenol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of CYP17A1 protein; bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein]]; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP17A1 mRNA; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]]; Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]; Triiodothyronine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 protein]
CTD
PMID:18336853 PMID:21610156 PMID:21726595 PMID:22079614 PMID:22546480 PMID:24014645 PMID:34896276 More...
NCBI chr10:102,830,531...102,837,413
Ensembl chr10:102,830,531...102,837,472
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
multiple interactions increases expression increases activity
ISO EXP
[vinclozolin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP19A1 mRNA; Atrazine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein]; Atrazine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 mRNA]; bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein]; formestane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein]; Methoxychlor inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of CYP19A1 protein] [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP19A1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP19A1 protein
CTD
PMID:10746939 PMID:18815356 PMID:21126571 PMID:21610156 PMID:22120136 PMID:23583632 PMID:28859905 PMID:30951242 More...
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
increases expression
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP1B1 protein
CTD
PMID:7588239 PMID:22079614
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
CYP21A2
cytochrome P450 family 21 subfamily A member 2
increases expression multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP21A2 mRNA [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP21A1 mRNA bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP21A2 mRNA]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP21A2 mRNA]
CTD
PMID:21610156 PMID:22079614 PMID:22546480 PMID:34896276
NCBI chr 6:32,038,415...32,041,644
Ensembl chr 6:32,038,327...32,041,644
G
CYP27A1
cytochrome P450 family 27 subfamily A member 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP27A1 mRNA
CTD
PMID:22079614
NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP2E1 mRNA
CTD
PMID:22079614
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
CYP2F1
cytochrome P450 family 2 subfamily F member 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP2F1 mRNA
CTD
PMID:22079614
NCBI chr19:41,114,432...41,128,381
Ensembl chr19:41,114,432...41,128,381
G
CYP3A5
cytochrome P450 family 3 subfamily A member 5
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP3A5 mRNA
CTD
PMID:22079614
NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
G
CYP3A7
cytochrome P450 family 3 subfamily A member 7
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CYP3A7 mRNA
CTD
PMID:22079614
NCBI chr 7:99,705,036...99,735,196
Ensembl chr 7:99,705,036...99,735,196
G
CYP51A1
cytochrome P450 family 51 subfamily A member 1
increases expression multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP51A1 mRNA [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA; [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 mRNA]; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP51 protein]
CTD
PMID:18467523 PMID:22079614
NCBI chr 7:92,112,153...92,134,803
Ensembl chr 7:92,084,987...92,134,803
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP8B1 mRNA
CTD
PMID:22079614
NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
G
CYTH1
cytohesin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYTH1 mRNA
CTD
PMID:22079614
NCBI chr17:78,674,048...78,782,273
Ensembl chr17:78,674,048...78,782,297
G
DACH2
dachshund family transcription factor 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DACH2 mRNA
CTD
PMID:22079614
NCBI chr X:86,148,451...86,832,602
Ensembl chr X:86,148,451...86,832,604
G
DACT1
dishevelled binding antagonist of beta catenin 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DACT1 mRNA
CTD
PMID:22079614
NCBI chr14:58,634,061...58,648,321
Ensembl chr14:58,633,967...58,648,321
G
DAZ2
deleted in azoospermia 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DAZ2 mRNA
CTD
PMID:22079614
NCBI chr Y:23,219,457...23,291,356
Ensembl chr Y:23,219,447...23,291,356
G
DBIL5P
diazepam binding inhibitor-like 5, pseudogene
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DBIL5P mRNA
CTD
PMID:22079614
NCBI chr17:752,333...755,336
Ensembl chr17:752,884...753,133
G
DCAF12L1
DDB1 and CUL4 associated factor 12 like 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DCAF12L1 mRNA
CTD
PMID:22079614
NCBI chr X:126,549,383...126,552,814
Ensembl chr X:126,549,383...126,552,814
G
DCBLD2
discoidin, CUB and LCCL domain containing 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DCBLD2 mRNA
CTD
PMID:22079614
NCBI chr 3:98,795,941...98,901,695
Ensembl chr 3:98,795,941...98,901,695
G
DGAT2
diacylglycerol O-acyltransferase 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DGAT2 mRNA
CTD
PMID:22079614
NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
G
DGKB
diacylglycerol kinase beta
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DGKB mRNA
CTD
PMID:22079614
NCBI chr 7:14,145,049...14,974,858
Ensembl chr 7:14,145,049...14,974,777
G
DHCR24
24-dehydrocholesterol reductase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DHCR24 mRNA
CTD
PMID:22079614
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
G
DHCR7
7-dehydrocholesterol reductase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DHCR7 mRNA
CTD
PMID:22079614
NCBI chr11:71,434,411...71,448,393
Ensembl chr11:71,428,193...71,452,868
G
DHRS2
dehydrogenase/reductase 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DHRS2 mRNA
CTD
PMID:22079614
NCBI chr14:23,630,115...23,645,639
Ensembl chr14:23,630,115...23,645,639
G
DHRS3
dehydrogenase/reductase 3
multiple interactions
EXP
7-propyl spirolactone inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein; Aldosterone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of DHRS3 protein]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]
CTD
PMID:23275455
NCBI chr 1:12,567,910...12,618,210
Ensembl chr 1:12,567,909...12,620,133
G
DIO2
iodothyronine deiodinase 2
multiple interactions increases activity
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of and results in increased activity of DIO2 protein 8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein Acetylcysteine inhibits the reaction [Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]]; Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]; Sodium Selenite inhibits the reaction [Hydrogen Peroxide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO2 protein]]
CTD
PMID:11425850 PMID:18420745
NCBI chr14:80,197,526...80,231,057
Ensembl chr14:80,197,526...80,387,757
G
DIO3
iodothyronine deiodinase 3
multiple interactions
ISO
Acetylcysteine inhibits the reaction [[Hydrogen Peroxide co-treated with Sodium Selenite] promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]]; Acetylcysteine inhibits the reaction [Hydrogen Peroxide promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]]; Hydrogen Peroxide promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased activity of DIO3 protein]
CTD
PMID:18420745
NCBI chr14:101,561,495...101,563,452
Ensembl chr14:101,560,139...101,563,452
G
DKK1
dickkopf WNT signaling pathway inhibitor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DKK1 mRNA
CTD
PMID:22079614
NCBI chr10:52,314,281...52,317,657
Ensembl chr10:52,314,281...52,318,042
G
DLEU2
deleted in lymphocytic leukemia 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DLEU2 mRNA
CTD
PMID:22079614
NCBI chr13:49,982,549...50,125,541
Ensembl chr13:49,956,670...50,125,720
G
DNAH5
dynein axonemal heavy chain 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DNAH5 mRNA
CTD
PMID:22079614
NCBI chr 5:13,690,328...14,011,818
Ensembl chr 5:13,690,328...14,011,818
G
DNAJB3
DnaJ heat shock protein family (Hsp40) member B3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DNAJB3 mRNA
CTD
PMID:22079614
NCBI chr 2:233,742,750...233,743,998
Ensembl chr 2:233,743,188...233,743,916 Ensembl chr 2:233,743,188...233,743,916
G
DNAJB7
DnaJ heat shock protein family (Hsp40) member B7
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DNAJB7 mRNA
CTD
PMID:22079614
NCBI chr22:40,859,549...40,862,113
Ensembl chr22:40,859,549...40,862,113
G
DNAJB9
DnaJ heat shock protein family (Hsp40) member B9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DNAJB9 mRNA
CTD
PMID:22079614
NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
G
DNER
delta/notch like EGF repeat containing
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DNER mRNA
CTD
PMID:22079614
NCBI chr 2:229,357,629...229,714,555
Ensembl chr 2:229,357,629...229,714,555
G
DOCK11
dedicator of cytokinesis 11
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DOCK11 mRNA
CTD
PMID:22079614
NCBI chr X:118,495,815...118,686,147
Ensembl chr X:118,495,815...118,686,163
G
DOK5
docking protein 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DOK5 mRNA
CTD
PMID:22079614
NCBI chr20:54,475,593...54,651,169
Ensembl chr20:54,475,593...54,651,169
G
DUSP1
dual specificity phosphatase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DUSP1 mRNA
CTD
PMID:22079614
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP16
dual specificity phosphatase 16
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DUSP16 mRNA
CTD
PMID:22079614
NCBI chr12:12,473,282...12,562,863
Ensembl chr12:12,473,282...12,562,863
G
DUSP4
dual specificity phosphatase 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of DUSP4 mRNA
CTD
PMID:20147733
NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
G
DUSP6
dual specificity phosphatase 6
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of DUSP6 mRNA
CTD
PMID:22079614
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
EBP
EBP cholestenol delta-isomerase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EBP mRNA
CTD
PMID:22079614
NCBI chr X:48,521,808...48,528,716
Ensembl chr X:48,521,799...48,528,716
G
ECHS1
enoyl-CoA hydratase, short chain 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ECHS1 mRNA
CTD
PMID:22079614
NCBI chr10:133,362,485...133,373,354
Ensembl chr10:133,362,485...133,373,354
G
EGF
epidermal growth factor
multiple interactions
ISO
EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]]
CTD
PMID:18467523
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
G
EGFR
epidermal growth factor receptor
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGFR mRNA
CTD
PMID:22079614
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
G
EGR1
early growth response 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGR1 mRNA
CTD
PMID:22079614
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
EGR2
early growth response 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGR2 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
G
ELP1
elongator acetyltransferase complex subunit 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ELP1 mRNA
CTD
PMID:22079614
NCBI chr 9:108,867,517...108,934,124
Ensembl chr 9:108,866,898...108,934,328
G
EMP2
epithelial membrane protein 2
multiple interactions decreases expression
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of EMP2 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EMP2 mRNA
CTD
PMID:16997883 PMID:22079614
NCBI chr16:10,528,422...10,580,598
Ensembl chr16:10,528,422...10,580,632
G
ENOX1
ecto-NOX disulfide-thiol exchanger 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ENOX1 mRNA
CTD
PMID:20147733
NCBI chr13:43,213,130...43,786,972
Ensembl chr13:43,213,130...43,786,972
G
EP300
E1A binding protein p300
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EP300 mRNA
CTD
PMID:22079614
NCBI chr22:41,092,592...41,180,077
Ensembl chr22:41,092,510...41,180,077
G
EPG5
ectopic P-granules 5 autophagy tethering factor
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EPG5 mRNA
CTD
PMID:20147733
NCBI chr18:45,800,581...45,967,329
Ensembl chr18:45,800,581...45,967,329
G
EPHX1
epoxide hydrolase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EPHX1 mRNA
CTD
PMID:22079614
NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
G
ERAP1
endoplasmic reticulum aminopeptidase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ERAP1 mRNA
CTD
PMID:22079614
NCBI chr 5:96,760,813...96,935,854
Ensembl chr 5:96,760,810...96,808,100
G
ERF
ETS2 repressor factor
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ERF mRNA
CTD
PMID:22079614
NCBI chr19:42,247,569...42,255,128
Ensembl chr19:42,247,569...42,255,128
G
ESR2
estrogen receptor 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ESR2 mRNA
CTD
PMID:22079614
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
ESRRA
estrogen related receptor alpha
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ESRRA mRNA
CTD
PMID:23166782
NCBI chr11:64,305,524...64,316,743
Ensembl chr11:64,305,497...64,316,743
G
ESRRG
estrogen related receptor gamma
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ESRRG mRNA
CTD
PMID:22079614
NCBI chr 1:216,503,246...217,137,702
Ensembl chr 1:216,503,246...217,137,755
G
ETNPPL
ethanolamine-phosphate phospho-lyase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ETNPPL mRNA
CTD
PMID:22079614
NCBI chr 4:108,742,053...108,763,053
Ensembl chr 4:108,742,048...108,763,054
G
ETV1
ETS variant transcription factor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ETV1 mRNA
CTD
PMID:20147733
NCBI chr 7:13,891,229...13,991,425
Ensembl chr 7:13,891,229...13,991,425
G
ETV5
ETS variant transcription factor 5
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ETV5 mRNA
CTD
PMID:22079614
NCBI chr 3:186,046,314...186,109,089
Ensembl chr 3:186,046,314...186,110,318
G
EZH2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EZH2 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of EZH2 protein [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 mRNA; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in decreased expression of EZH2 protein; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]
CTD
PMID:21903722
NCBI chr 7:148,807,383...148,884,291
Ensembl chr 7:148,807,257...148,884,321
G
F2RL2
coagulation factor II thrombin receptor like 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of F2RL2 mRNA
CTD
PMID:20147733
NCBI chr 5:76,615,482...76,623,403
Ensembl chr 5:76,615,482...76,623,413
G
FABP1
fatty acid binding protein 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FABP1 mRNA
CTD
PMID:22079614
NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
G
FADS1
fatty acid desaturase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FADS1 mRNA
CTD
PMID:22079614
NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318
G
FASLG
Fas ligand
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FASLG protein
CTD
PMID:16709600
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FBLN1
fibulin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FBLN1 mRNA
CTD
PMID:15774544
NCBI chr22:45,502,883...45,601,135
Ensembl chr22:45,502,238...45,601,135
G
FBXO32
F-box protein 32
multiple interactions
EXP
[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA]
CTD
PMID:23275455
NCBI chr 8:123,497,889...123,541,206
Ensembl chr 8:123,497,889...123,541,206
G
FDFT1
farnesyl-diphosphate farnesyltransferase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FDFT1 mRNA
CTD
PMID:22079614
NCBI chr 8:11,795,582...11,839,309
Ensembl chr 8:11,795,573...11,839,395
G
FDX1
ferredoxin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FDX1 mRNA
CTD
PMID:22079614
NCBI chr11:110,429,331...110,464,884
Ensembl chr11:110,429,948...110,464,884
G
FDXR
ferredoxin reductase
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FDXR protein Hydrocarbons, Chlorinated inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FDXR protein]
CTD
PMID:24740604
NCBI chr17:74,862,497...74,872,994
Ensembl chr17:74,862,497...74,873,031
G
FER1L6
fer-1 like family member 6
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FER1L6 mRNA
CTD
PMID:20147733
NCBI chr 8:123,851,987...124,120,061
Ensembl chr 8:123,851,987...124,120,061
G
FGF10
fibroblast growth factor 10
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FGF10 mRNA
CTD
PMID:20147733
NCBI chr 5:44,300,247...44,389,420
Ensembl chr 5:44,300,247...44,389,706
G
FGF13
fibroblast growth factor 13
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FGF13 mRNA
CTD
PMID:22079614
NCBI chr X:138,614,727...139,205,023
Ensembl chr X:138,614,727...139,222,777
G
FGF9
fibroblast growth factor 9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FGF9 mRNA
CTD
PMID:22079614
NCBI chr13:21,671,073...21,704,498
Ensembl chr13:21,671,073...21,704,498
G
FHL2
four and a half LIM domains 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FHL2 mRNA
CTD
PMID:22079614
NCBI chr 2:105,357,712...105,438,529
Ensembl chr 2:105,357,712...105,438,513
G
FLOT1
flotillin 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of FLOT1 mRNA
CTD
PMID:16997883
NCBI chr 6:30,727,709...30,742,687
Ensembl chr 6:30,727,709...30,742,732
G
FLOT2
flotillin 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FLOT2 mRNA
CTD
PMID:22079614
NCBI chr17:28,879,339...28,897,733
Ensembl chr17:28,879,335...28,897,733
G
FN1
fibronectin 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FN1 mRNA
CTD
PMID:22079614
NCBI chr 2:215,360,865...215,436,068
Ensembl chr 2:215,360,440...215,436,073
G
FOXO1
forkhead box O1
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 protein; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein]; Hydrogen Peroxide inhibits the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 mRNA]; Hydrogen Peroxide inhibits the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of FOXO1 protein]
CTD
PMID:16709600
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641
G
FOXO3
forkhead box O3
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] inhibits the reaction [Hydrogen Peroxide results in increased expression of FOXO3 mRNA]; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] inhibits the reaction [Hydrogen Peroxide results in increased expression of FOXO3 protein]; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of FOXO3 mRNA]
CTD
PMID:16709600
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
G
FOXR1
forkhead box R1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FOXR1 mRNA
CTD
PMID:22079614
NCBI chr11:118,971,761...118,981,287
Ensembl chr11:118,971,712...118,981,287
G
FRAS1
Fraser extracellular matrix complex subunit 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FRAS1 mRNA
CTD
PMID:22079614
NCBI chr 4:78,057,323...78,544,269
Ensembl chr 4:78,057,323...78,544,269
G
FSHB
follicle stimulating hormone subunit beta
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FSHB mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FSHB protein Tetrachlorodibenzodioxin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FSHB mRNA]
CTD
PMID:8404651 PMID:10746652 PMID:21467749
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
G
FZD10
frizzled class receptor 10
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FZD10 mRNA
CTD
PMID:22079614
NCBI chr12:130,162,464...130,165,740
Ensembl chr12:130,162,459...130,165,740
G
FZD4
frizzled class receptor 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of FZD4 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr11:86,945,679...86,955,395
Ensembl chr11:86,945,679...86,955,395
G
FZD7
frizzled class receptor 7
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of FZD7 mRNA
CTD
PMID:22079614
NCBI chr 2:202,033,855...202,038,441
Ensembl chr 2:202,033,855...202,038,441
G
GABBR2
gamma-aminobutyric acid type B receptor subunit 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GABBR2 mRNA
CTD
PMID:22079614
NCBI chr 9:98,288,109...98,708,935
Ensembl chr 9:98,288,109...98,708,935
G
GABRA4
gamma-aminobutyric acid type A receptor subunit alpha4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GABRA4 mRNA
CTD
PMID:22079614
NCBI chr 4:46,918,900...46,993,581
Ensembl chr 4:46,918,900...46,993,581
G
GABRG1
gamma-aminobutyric acid type A receptor subunit gamma1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GABRG1 mRNA
CTD
PMID:22079614
NCBI chr 4:46,035,769...46,124,054
Ensembl chr 4:46,035,769...46,124,054
G
GADD45A
growth arrest and DNA damage inducible alpha
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of GADD45A mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of GADD45A protein
CTD
PMID:16709600
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GALNT12
polypeptide N-acetylgalactosaminyltransferase 12
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GALNT12 mRNA
CTD
PMID:20147733
NCBI chr 9:98,807,670...98,850,081
Ensembl chr 9:98,807,670...98,850,081
G
GALR1
galanin receptor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GALR1 mRNA
CTD
PMID:22079614
NCBI chr18:77,249,848...77,277,900
Ensembl chr18:77,249,848...77,277,900
G
GAP43
growth associated protein 43
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GAP43 mRNA
CTD
PMID:20147733
NCBI chr 3:115,623,510...115,721,483
Ensembl chr 3:115,623,510...115,721,490
G
GCK
glucokinase
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GCK mRNA
CTD
PMID:22079614
NCBI chr 7:44,143,213...44,189,439
Ensembl chr 7:44,143,213...44,198,170
G
GCNA
germ cell nuclear acidic peptidase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GCNA mRNA
CTD
PMID:22079614
NCBI chr X:71,578,437...71,613,583
Ensembl chr X:71,578,437...71,613,583
G
GCSAM
germinal center associated signaling and motility
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GCSAM mRNA
CTD
PMID:22079614
NCBI chr 3:112,120,839...112,133,248
Ensembl chr 3:112,120,839...112,133,270
G
GDF10
growth differentiation factor 10
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GDF10 mRNA
CTD
PMID:22079614
NCBI chr10:47,300,197...47,313,577
Ensembl chr10:47,300,197...47,313,577
G
GDF15
growth differentiation factor 15
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GDF15 mRNA
CTD
PMID:22079614
NCBI chr19:18,386,158...18,389,176
Ensembl chr19:18,374,731...18,389,176
G
GFAP
glial fibrillary acidic protein
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GFAP mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in decreased expression of GFAP mRNA]
CTD
PMID:15994020
NCBI chr17:44,903,159...44,915,500
Ensembl chr17:44,903,159...44,916,937
G
GFPT2
glutamine-fructose-6-phosphate transaminase 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GFPT2 mRNA
CTD
PMID:20147733
NCBI chr 5:180,300,698...180,353,336
Ensembl chr 5:180,300,698...180,353,336
G
GIMAP8
GTPase, IMAP family member 8
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GIMAP8 mRNA
CTD
PMID:22079614
NCBI chr 7:150,450,630...150,479,393
Ensembl chr 7:150,450,630...150,479,393
G
GJA1
gap junction protein alpha 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GJA1 mRNA
CTD
PMID:22079614
NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
G
GJB2
gap junction protein beta 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GJB2 mRNA
CTD
PMID:22079614
NCBI chr13:20,187,470...20,192,938
Ensembl chr13:20,187,463...20,192,938
G
GK
glycerol kinase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GK mRNA
CTD
PMID:22079614
NCBI chr X:30,653,423...30,731,462
Ensembl chr X:30,653,359...30,731,462
G
GLIPR1
GLI pathogenesis related 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GLIPR1 mRNA
CTD
PMID:20147733
NCBI chr12:75,480,755...75,503,863
Ensembl chr12:75,480,753...75,503,863
G
GLRX
glutaredoxin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GLRX mRNA
CTD
PMID:22079614
NCBI chr 5:95,813,849...95,822,726
Ensembl chr 5:95,751,319...95,822,726
G
GNAI2
G protein subunit alpha i2
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI2 protein]
CTD
PMID:19252090
NCBI chr 3:50,227,068...50,263,358
Ensembl chr 3:50,226,292...50,259,362
G
GNAI3
G protein subunit alpha i3
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of GNAI3 protein]
CTD
PMID:19252090
NCBI chr 1:109,548,615...109,600,195
Ensembl chr 1:109,548,615...109,600,195
G
GNG2
G protein subunit gamma 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GNG2 mRNA
CTD
PMID:22079614
NCBI chr14:51,826,174...51,969,795
Ensembl chr14:51,826,195...51,979,342
G
GPR22
G protein-coupled receptor 22
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GPR22 mRNA
CTD
PMID:22079614
NCBI chr 7:107,470,057...107,477,845
Ensembl chr 7:107,470,018...107,475,684
G
GPR37
G protein-coupled receptor 37
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GPR37 mRNA
CTD
PMID:22079614
NCBI chr 7:124,743,885...124,765,792
Ensembl chr 7:124,743,885...124,765,792
G
GPX1
glutathione peroxidase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GPX1 mRNA
CTD
PMID:22079614
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GRB10
growth factor receptor bound protein 10
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GRB10 mRNA
CTD
PMID:22079614
NCBI chr 7:50,590,068...50,793,453
Ensembl chr 7:50,590,063...50,793,462
G
GRB14
growth factor receptor bound protein 14
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GRB14 mRNA
CTD
PMID:22079614
NCBI chr 2:164,492,417...164,621,482
Ensembl chr 2:164,492,417...164,621,482
G
GREM2
gremlin 2, DAN family BMP antagonist
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GREM2 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 1:240,489,573...240,612,155
Ensembl chr 1:240,489,573...240,612,155
G
GRIA1
glutamate ionotropic receptor AMPA type subunit 1
multiple interactions
EXP
[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]
CTD
PMID:23275455
NCBI chr 5:153,489,615...153,813,869
Ensembl chr 5:153,489,615...153,813,869
G
GRIN3A
glutamate ionotropic receptor NMDA type subunit 3A
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GRIN3A mRNA
CTD
PMID:22079614
NCBI chr 9:101,569,352...101,738,647
Ensembl chr 9:101,569,352...101,738,647
G
GSTA2
glutathione S-transferase alpha 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GSTA2 mRNA
CTD
PMID:22079614
NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
G
GSTM2
glutathione S-transferase mu 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GSTM2 mRNA
CTD
PMID:22079614
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
G
GSTM4
glutathione S-transferase mu 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GSTM4 mRNA
CTD
PMID:20147733
NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496
G
HAS2
hyaluronan synthase 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HAS2 mRNA
CTD
PMID:20147733
NCBI chr 8:121,612,116...121,641,440
Ensembl chr 8:121,612,116...121,641,440
G
HBG1
hemoglobin subunit gamma 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HBG1 mRNA
CTD
PMID:22079614
NCBI chr11:5,248,269...5,249,857
Ensembl chr11:5,248,269...5,249,857
G
HDAC3
histone deacetylase 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HDAC3 mRNA
CTD
PMID:22079614
NCBI chr 5:141,620,881...141,636,849
Ensembl chr 5:141,620,876...141,636,849
G
HDAC5
histone deacetylase 5
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HDAC5 mRNA
CTD
PMID:22079614
NCBI chr17:44,076,753...44,123,641
Ensembl chr17:44,076,746...44,123,702
G
HEY2
hes related family bHLH transcription factor with YRPW motif 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HEY2 mRNA
CTD
PMID:22079614
NCBI chr 6:125,749,632...125,761,269
Ensembl chr 6:125,747,664...125,761,269
G
HLF
HLF transcription factor, PAR bZIP family member
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HLF mRNA
CTD
PMID:22079614
NCBI chr17:55,264,960...55,325,187
Ensembl chr17:55,264,960...55,325,187
G
HMGA1
high mobility group AT-hook 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HMGA1 mRNA
CTD
PMID:22079614
NCBI chr 6:34,236,873...34,246,231
Ensembl chr 6:34,236,873...34,246,231
G
HMGCS1
3-hydroxy-3-methylglutaryl-CoA synthase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HMGCS1 mRNA
CTD
PMID:22079614
NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
G
HMOX1
heme oxygenase 1
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HMOX1 mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of HMOX1 mRNA]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HMOX1 mRNA]
CTD
PMID:15179140 PMID:15994020
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNF4G
hepatocyte nuclear factor 4 gamma
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HNF4G mRNA
CTD
PMID:22079614
NCBI chr 8:75,407,649...75,566,834
Ensembl chr 8:75,407,914...75,566,834
G
HOXB9
homeobox B9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HOXB9 mRNA
CTD
PMID:22079614
NCBI chr17:48,621,156...48,626,358
Ensembl chr17:48,621,156...48,626,358
G
HPCA
hippocalcin
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HPCA mRNA
CTD
PMID:22079614
NCBI chr 1:32,885,996...32,894,646
Ensembl chr 1:32,885,994...32,898,441
G
HS3ST1
heparan sulfate-glucosamine 3-sulfotransferase 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HS3ST1 mRNA
CTD
PMID:22079614
NCBI chr 4:11,393,150...11,434,327
Ensembl chr 4:11,393,150...11,429,564
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
multiple interactions
EXP
4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA]; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of and results in increased activity of HSD11B1 protein; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of HSD11B1 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA; Hydrocortisone promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B1 mRNA]
CTD
PMID:23275455
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
G
HSD11B2
hydroxysteroid 11-beta dehydrogenase 2
decreases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD11B2 mRNA [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD11B2 protein
CTD
PMID:22079614 PMID:23275455
NCBI chr16:67,429,801...67,437,553
Ensembl chr16:67,430,652...67,437,553
G
HSD17B1
hydroxysteroid 17-beta dehydrogenase 1
multiple interactions increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [bisphenol A results in decreased expression of HSD17B1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B1 mRNA
CTD
PMID:18815356 PMID:21273127
NCBI chr17:42,552,923...42,555,214
Ensembl chr17:42,552,922...42,555,214
G
HSD17B14
hydroxysteroid 17-beta dehydrogenase 14
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD17B14 mRNA
CTD
PMID:22079614
NCBI chr19:48,813,018...48,836,491
Ensembl chr19:48,813,018...48,836,510
G
HSD17B2
hydroxysteroid 17-beta dehydrogenase 2
multiple interactions increases expression
EXP ISO
bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA] [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] affects the expression of HSD17B2 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 protein
CTD
PMID:18815356 PMID:21273127 PMID:21610156
NCBI chr16:82,035,253...82,098,534
Ensembl chr16:82,035,004...82,098,534
G
HSD17B3
hydroxysteroid 17-beta dehydrogenase 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B3 mRNA
CTD
PMID:22079614
NCBI chr 9:96,235,306...96,302,176
Ensembl chr 9:96,235,306...96,302,176
G
HSD17B4
hydroxysteroid 17-beta dehydrogenase 4
multiple interactions
EXP
[4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of HSD17B4 protein
CTD
PMID:18336853
NCBI chr 5:119,452,497...119,542,332
Ensembl chr 5:119,452,465...119,637,199
G
HSD17B7
hydroxysteroid 17-beta dehydrogenase 7
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B7 mRNA
CTD
PMID:22079614
NCBI chr 1:162,790,702...162,812,823
Ensembl chr 1:162,790,702...162,812,823
G
HSD3B1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
decreases expression increases expression multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSD3B1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 protein 2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA]]; Triiodothyronine inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA]
CTD
PMID:18815356 PMID:21726595 PMID:22079614
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
G
HSD3B2
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
multiple interactions increases expression
EXP
[4-nitro-3-cresol co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of HSD3B2 protein; bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B2 mRNA]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B2 mRNA]
CTD
PMID:18336853 PMID:22079614 PMID:22546480 PMID:34896276
NCBI chr 1:119,414,931...119,423,034
Ensembl chr 1:119,414,931...119,423,035
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSP90AA1 mRNA
CTD
PMID:22079614
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSPA1A
heat shock protein family A (Hsp70) member 1A
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSPA1A mRNA
CTD
PMID:22079614
NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
G
HSPA5
heat shock protein family A (Hsp70) member 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSPA5 mRNA
CTD
PMID:22079614
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPA8
heat shock protein family A (Hsp70) member 8
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of HSPA8 mRNA
CTD
PMID:22079614
NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
G
HSPH1
heat shock protein family H (Hsp110) member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSPH1 mRNA
CTD
PMID:22079614
NCBI chr13:31,134,973...31,162,388
Ensembl chr13:31,134,973...31,162,388
G
ICAM1
intercellular adhesion molecule 1
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Reactive Oxygen Species results in increased expression of ICAM1 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]
CTD
PMID:10495789
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ICAM2
intercellular adhesion molecule 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ICAM2 mRNA
CTD
PMID:22079614
NCBI chr17:64,002,595...64,020,633
Ensembl chr17:64,002,594...64,020,634
G
ID1
inhibitor of DNA binding 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ID1 mRNA
CTD
PMID:22079614
NCBI chr20:31,605,289...31,606,510
Ensembl chr20:31,605,283...31,606,515
G
IDI1
isopentenyl-diphosphate delta isomerase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IDI1 mRNA
CTD
PMID:22079614
NCBI chr10:1,039,152...1,056,704
Ensembl chr10:1,039,152...1,049,119
G
IER3
immediate early response 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IER3 mRNA
CTD
PMID:20147733
NCBI chr 6:30,743,199...30,744,547
Ensembl chr 6:30,743,199...30,744,548
G
IGF1
insulin like growth factor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGF1 mRNA
CTD
PMID:20147733
NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
G
IGF2BP2
insulin like growth factor 2 mRNA binding protein 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGF2BP2 mRNA
CTD
PMID:22079614
NCBI chr 3:185,643,130...185,825,042
Ensembl chr 3:185,643,130...185,825,042
G
IGFBP1
insulin like growth factor binding protein 1
multiple interactions increases expression decreases expression increases secretion
EXP
1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; 4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]]; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein; Dexamethasone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of IGFBP1 mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of IGFBP1 protein]; Hydrocortisone promotes the reaction [Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]]; PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 protein 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IGFBP1 protein 8-Bromo Cyclic Adenosine Monophosphate results in increased secretion of IGFBP1 protein
CTD
PMID:16709600 PMID:17065600 PMID:18815356 PMID:20147733 PMID:21273127 PMID:21903722 PMID:23275455 More...
NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
G
IGFBP5
insulin like growth factor binding protein 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP5 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
G
IKZF1
IKAROS family zinc finger 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IKZF1 mRNA
CTD
PMID:22079614
NCBI chr 7:50,303,455...50,405,101
Ensembl chr 7:50,304,068...50,405,101
G
IL18
interleukin 18
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL18 mRNA
CTD
PMID:22079614
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
G
IL1A
interleukin 1 alpha
multiple interactions increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [IL1A protein results in increased secretion of CCL2 protein]] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL1A mRNA
CTD
PMID:11230753 PMID:22079614
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]
CTD
PMID:11112151
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL27RA
interleukin 27 receptor subunit alpha
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL27RA mRNA
CTD
PMID:22079614
NCBI chr19:14,031,762...14,053,218
Ensembl chr19:14,031,762...14,053,218
G
IL32
interleukin 32
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of IL32 mRNA
CTD
PMID:16997883
NCBI chr16:3,065,403...3,069,530
Ensembl chr16:3,065,297...3,082,192
G
IL4
interleukin 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL4 mRNA
CTD
PMID:22079614
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL4R
interleukin 4 receptor
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL4R mRNA
CTD
PMID:20147733
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL6
interleukin 6
multiple interactions
EXP ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of IL6 mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
CTD
PMID:16997883 PMID:21803157
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL7R
interleukin 7 receptor
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IL7R mRNA
CTD
PMID:22079614
NCBI chr 5:35,856,891...35,879,603
Ensembl chr 5:35,852,695...35,879,603
G
INHBA
inhibin subunit beta A
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of INHBA mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 7:41,685,114...41,705,406
Ensembl chr 7:41,667,168...41,705,834
G
INSIG1
insulin induced gene 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of INSIG1 mRNA
CTD
PMID:22079614
NCBI chr 7:155,297,878...155,310,235
Ensembl chr 7:155,297,776...155,310,235
G
INSM2
INSM transcriptional repressor 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of INSM2 mRNA
CTD
PMID:22079614
NCBI chr14:35,534,164...35,537,054
Ensembl chr14:35,534,164...35,537,054
G
IQGAP2
IQ motif containing GTPase activating protein 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of IQGAP2 mRNA
CTD
PMID:22079614
NCBI chr 5:76,403,285...76,708,132
Ensembl chr 5:76,403,285...76,708,132
G
IRS1
insulin receptor substrate 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IRS1 mRNA
CTD
PMID:22079614
NCBI chr 2:226,731,312...226,799,820
Ensembl chr 2:226,731,312...226,799,820
G
ISM1
isthmin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ISM1 mRNA
CTD
PMID:20147733
NCBI chr20:13,221,274...13,326,723
Ensembl chr20:13,221,274...13,300,651
G
ITGA2
integrin subunit alpha 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ITGA2 mRNA
CTD
PMID:20147733
NCBI chr 5:52,989,352...53,094,779
Ensembl chr 5:52,989,340...53,094,779
G
ITPKB
inositol-trisphosphate 3-kinase B
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ITPKB mRNA
CTD
PMID:22079614
NCBI chr 1:226,631,690...226,739,282
Ensembl chr 1:226,631,690...226,739,323
G
JAG1
jagged canonical Notch ligand 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of JAG1 mRNA
CTD
PMID:22079614
NCBI chr20:10,637,684...10,673,999
Ensembl chr20:10,637,684...10,673,999
G
JARID2
jumonji and AT-rich interaction domain containing 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of JARID2 mRNA
CTD
PMID:20147733
NCBI chr 6:15,246,069...15,522,042
Ensembl chr 6:15,246,069...15,522,042
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of and results in increased phosphorylation of JUN protein
CTD
PMID:28697429
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of JUND mRNA
CTD
PMID:22079614
NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
G
KCNC2
potassium voltage-gated channel subfamily C member 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KCNC2 mRNA
CTD
PMID:22079614
NCBI chr12:75,040,078...75,209,839
Ensembl chr12:75,040,077...75,209,839
G
KCND2
potassium voltage-gated channel subfamily D member 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCND2 mRNA
CTD
PMID:22079614
NCBI chr 7:120,272,908...120,750,337
Ensembl chr 7:120,273,175...120,750,337
G
KCNE4
potassium voltage-gated channel subfamily E regulatory subunit 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCNE4 mRNA
CTD
PMID:22079614
NCBI chr 2:223,052,190...223,055,637
Ensembl chr 2:223,052,190...223,198,399
G
KCNH6
potassium voltage-gated channel subfamily H member 6
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KCNH6 mRNA
CTD
PMID:22079614
NCBI chr17:63,523,358...63,548,992
Ensembl chr17:63,523,334...63,548,977
G
KCNQ1
potassium voltage-gated channel subfamily Q member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCNQ1 mRNA
CTD
PMID:22079614
NCBI chr11:2,445,008...2,849,105
Ensembl chr11:2,444,654...2,849,105
G
KCTD12
potassium channel tetramerization domain containing 12
multiple interactions increases expression decreases expression
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of KCTD12 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KCTD12 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KCTD12 mRNA
CTD
PMID:16997883 PMID:20147733 PMID:22079614
NCBI chr13:76,880,175...76,886,405
Ensembl chr13:76,880,175...76,886,405
G
KIF5C
kinesin family member 5C
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KIF5C mRNA
CTD
PMID:22079614
NCBI chr 2:148,875,227...149,026,759
Ensembl chr 2:148,875,227...149,026,759
G
KIRREL3
kirre like nephrin family adhesion molecule 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KIRREL3 mRNA
CTD
PMID:22079614
NCBI chr11:126,423,358...127,000,870
Ensembl chr11:126,423,358...127,003,460
G
KLHL5
kelch like family member 5
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KLHL5 mRNA
CTD
PMID:22079614
NCBI chr 4:39,044,827...39,143,101
Ensembl chr 4:39,045,039...39,126,857
G
KLRC1
killer cell lectin like receptor C1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KLRC1 mRNA
CTD
PMID:22079614
NCBI chr12:10,442,264...10,454,685
Ensembl chr12:10,442,264...10,454,685
G
KLRC2
killer cell lectin like receptor C2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KLRC2 mRNA
CTD
PMID:22079614
NCBI chr12:10,430,599...10,436,010
Ensembl chr12:10,426,854...10,442,300
G
KLRC3
killer cell lectin like receptor C3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of KLRC3 mRNA
CTD
PMID:22079614
NCBI chr12:10,412,315...10,420,595
Ensembl chr12:10,412,315...10,420,595
G
KRT34
keratin 34
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KRT34 mRNA
CTD
PMID:20147733
NCBI chr17:41,377,669...41,383,816
Ensembl chr17:41,377,669...41,382,306
G
KRTAP1-5
keratin associated protein 1-5
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of KRTAP1-5 mRNA
CTD
PMID:20147733
NCBI chr17:41,026,026...41,027,208
Ensembl chr17:41,026,026...41,027,208
G
L3MBTL3
L3MBTL histone methyl-lysine binding protein 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of L3MBTL3 mRNA
CTD
PMID:22079614
NCBI chr 6:130,018,581...130,141,438
Ensembl chr 6:130,013,699...130,141,449
G
LAMA3
laminin subunit alpha 3
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LAMA3 mRNA
CTD
PMID:16997883
NCBI chr18:23,689,453...23,955,066
Ensembl chr18:23,689,453...23,956,222
G
LAMB3
laminin subunit beta 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LAMB3 mRNA
CTD
PMID:22079614
NCBI chr 1:209,614,870...209,652,425
Ensembl chr 1:209,614,870...209,652,425
G
LAMP3
lysosomal associated membrane protein 3
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LAMP3 mRNA
CTD
PMID:16997883
NCBI chr 3:183,122,215...183,163,813
Ensembl chr 3:183,122,215...183,163,839
G
LAT2
linker for activation of T cells family member 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LAT2 mRNA
CTD
PMID:22079614
NCBI chr 7:74,210,006...74,229,834
Ensembl chr 7:74,199,652...74,229,834
G
LDLR
low density lipoprotein receptor
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LDLR mRNA
CTD
PMID:22079614
NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
G
LEF1
lymphoid enhancer binding factor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LEF1 mRNA
CTD
PMID:22079614
NCBI chr 4:108,047,548...108,168,932
Ensembl chr 4:108,047,545...108,168,956
G
LEP
leptin
multiple interactions decreases response to substance
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]; LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; SB 203580 inhibits the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]] LEP protein results in decreased susceptibility to 8-Bromo Cyclic Adenosine Monophosphate
CTD
PMID:19849856
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
LEPR
leptin receptor
multiple interactions
EXP
LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased chemical synthesis of Progesterone]]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]
CTD
PMID:19849856
NCBI chr 1:65,420,652...65,641,559
Ensembl chr 1:65,420,652...65,641,559
G
LGALS1
galectin 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LGALS1 mRNA
CTD
PMID:22079614
NCBI chr22:37,675,636...37,679,802
Ensembl chr22:37,675,636...37,679,802
G
LGR4
leucine rich repeat containing G protein-coupled receptor 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LGR4 mRNA
CTD
PMID:20147733
NCBI chr11:27,365,961...27,472,790
Ensembl chr11:27,365,961...27,472,790
G
LHB
luteinizing hormone subunit beta
increases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHB mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHB protein Tetrachlorodibenzodioxin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHB mRNA]
CTD
PMID:8404651 PMID:21467749
NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
G
LHCGR
luteinizing hormone/choriogonadotropin receptor
decreases expression increases expression multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LHCGR mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHCGR mRNA T-2 Toxin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHCGR mRNA] Atrazine promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LHCGR mRNA]
CTD
PMID:22079614 PMID:23583632 PMID:30951242
NCBI chr 2:48,686,774...48,755,724
Ensembl chr 2:48,686,774...48,755,730
G
LIF
LIF interleukin 6 family cytokine
multiple interactions
EXP ISO
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of LIF mRNA [NR5A1 protein co-treated with LIF protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Tretinoin] results in increased abundance of Progesterone
CTD
PMID:16997883 PMID:21610156
NCBI chr22:30,240,453...30,246,759
Ensembl chr22:30,240,453...30,246,759
G
LIMCH1
LIM and calponin homology domains 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LIMCH1 mRNA
CTD
PMID:16997883
NCBI chr 4:41,359,607...41,700,044
Ensembl chr 4:41,359,607...41,700,044
G
LINGO1
leucine rich repeat and Ig domain containing 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LINGO1 mRNA
CTD
PMID:22079614
NCBI chr15:77,613,027...77,820,900
Ensembl chr15:77,613,027...77,820,900
G
LIPC
lipase C, hepatic type
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LIPC mRNA
CTD
PMID:22079614
NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
G
LMNB1
lamin B1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LMNB1 mRNA
CTD
PMID:22079614
NCBI chr 5:126,776,623...126,837,020
Ensembl chr 5:126,776,623...126,837,020
G
LMO3
LIM domain only 3
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LMO3 mRNA
CTD
PMID:16997883
NCBI chr12:16,548,372...16,610,174
Ensembl chr12:16,548,372...16,610,594
G
LOXL1
lysyl oxidase like 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of LOXL1 mRNA
CTD
PMID:16997883
NCBI chr15:73,926,462...73,952,136
Ensembl chr15:73,925,989...73,952,137
G
LPCAT1
lysophosphatidylcholine acyltransferase 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LPCAT1 mRNA
CTD
PMID:16997883
NCBI chr 5:1,461,427...1,523,960
Ensembl chr 5:1,456,480...1,523,962
G
LPL
lipoprotein lipase
increases expression decreases activity
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LPL mRNA 8-Bromo Cyclic Adenosine Monophosphate results in decreased activity of LPL protein
CTD
PMID:9032464 PMID:9414485
NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
G
LRRC17
leucine rich repeat containing 17
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LRRC17 mRNA
CTD
PMID:22079614
NCBI chr 7:102,913,000...102,945,111
Ensembl chr 7:102,913,000...102,945,111
G
LSS
lanosterol synthase
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of LSS mRNA
CTD
PMID:22079614
NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
G
LUM
lumican
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LUM mRNA
CTD
PMID:22079614
NCBI chr12:91,102,629...91,111,494
Ensembl chr12:91,102,629...91,111,494
G
LXN
latexin
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LXN mRNA
CTD
PMID:16997883
NCBI chr 3:158,666,414...158,672,648
Ensembl chr 3:158,645,822...158,672,648
G
LYPD1
LY6/PLAUR domain containing 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of LYPD1 mRNA
CTD
PMID:20147733
NCBI chr 2:132,643,286...132,671,526
Ensembl chr 2:132,643,286...132,671,579
G
LYVE1
lymphatic vessel endothelial hyaluronan receptor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of XLKD1 mRNA
CTD
PMID:22079614
NCBI chr11:10,556,966...10,568,665
Ensembl chr11:10,556,966...10,611,689
G
MAGEB10
MAGE family member B10
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MAGEB10 mRNA
CTD
PMID:22079614
NCBI chr X:27,807,990...27,823,014
Ensembl chr X:27,807,990...27,823,014
G
MAMDC2
MAM domain containing 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MAMDC2 mRNA
CTD
PMID:22079614
NCBI chr 9:70,043,581...70,226,972
Ensembl chr 9:70,043,848...70,226,972
G
MAN1A1
mannosidase alpha class 1A member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MAN1A1 mRNA
CTD
PMID:22079614
NCBI chr 6:119,177,205...119,350,605
Ensembl chr 6:119,177,205...119,349,761
G
MAP3K8
mitogen-activated protein kinase kinase kinase 8
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAP3K8 mRNA
CTD
PMID:22079614
NCBI chr10:30,434,021...30,461,833
Ensembl chr10:30,434,021...30,461,833
G
MAPK1
mitogen-activated protein kinase 1
multiple interactions
EXP ISO
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased activity of MAPK1 protein]; [1-Methyl-3-isobutylxanthine co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased activity of MAPK1 protein [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein; azalanstat inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]; EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein]]; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK1 protein] 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [anandamide results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK1 protein]
CTD
PMID:8526880 PMID:12657697 PMID:18467523 PMID:19252090
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK10
mitogen-activated protein kinase 10
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAPK10 mRNA
CTD
PMID:22079614
NCBI chr 4:86,010,405...86,594,074
Ensembl chr 4:85,990,007...86,594,625
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions decreases expression
EXP ISO
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased activity of MAPK3 protein]; [1-Methyl-3-isobutylxanthine co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased activity of MAPK3 protein [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein; azalanstat inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]; EGF protein inhibits the reaction [naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein]]; naphthol AS-E phosphate inhibits the reaction [[monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased phosphorylation of and results in increased activity of MAPK3 protein] 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAPK3 mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [anandamide results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [glyceryl 2-arachidonate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased phosphorylation of MAPK3 protein]
CTD
PMID:8526880 PMID:12657697 PMID:18467523 PMID:19252090 PMID:22079614
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPT
microtubule associated protein tau
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MAPT mRNA
CTD
PMID:22079614
NCBI chr17:45,894,554...46,028,334
Ensembl chr17:45,894,527...46,028,334
G
MC2R
melanocortin 2 receptor
increases expression multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MC2R mRNA [20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] promotes the reaction [NR5A1 protein binds to MC2R promoter]
CTD
PMID:21610156 PMID:22079614
NCBI chr18:13,882,044...13,915,707
Ensembl chr18:13,882,044...13,915,707
G
MCF2
MCF.2 cell line derived transforming sequence
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MCF2 mRNA
CTD
PMID:22079614
NCBI chr X:139,581,770...139,708,167
Ensembl chr X:139,581,770...139,708,216
G
MCF2L
MCF.2 cell line derived transforming sequence like
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MCF2L mRNA
CTD
PMID:22079614
NCBI chr13:112,894,335...113,099,742
Ensembl chr13:112,894,378...113,099,742
G
MDH1
malate dehydrogenase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MDH1 mRNA
CTD
PMID:22079614
NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197
G
MEDAG
mesenteric estrogen dependent adipogenesis
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MEDAG mRNA
CTD
PMID:20147733
NCBI chr13:30,906,271...30,925,572
Ensembl chr13:30,906,271...30,925,572
G
MERTK
MER proto-oncogene, tyrosine kinase
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MERTK mRNA
CTD
PMID:22079614
NCBI chr 2:111,898,607...112,029,561
Ensembl chr 2:111,898,607...112,029,561
G
METRNL
meteorin like, glial cell differentiation regulator
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of METRNL mRNA
CTD
PMID:22079614
NCBI chr17:83,079,609...83,095,122
Ensembl chr17:83,079,609...83,095,122
G
MGST1
microsomal glutathione S-transferase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MGST1 mRNA
CTD
PMID:22079614
NCBI chr12:16,347,115...16,593,331
Ensembl chr12:16,347,142...16,609,259
G
MIA2
MIA SH3 domain ER export factor 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MIA2 mRNA
CTD
PMID:22079614
NCBI chr14:39,233,915...39,388,522
Ensembl chr14:39,230,231...39,388,513
G
MICB
MHC class I polypeptide-related sequence B
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MICB mRNA
CTD
PMID:22079614
NCBI chr 6:31,494,918...31,511,124
Ensembl chr 6:31,494,881...31,511,124
G
MILR1
mast cell immunoglobulin like receptor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MILR1 mRNA
CTD
PMID:20147733
NCBI chr17:64,449,115...64,497,356
Ensembl chr17:64,449,037...64,468,643
G
MME
membrane metalloendopeptidase
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MME mRNA
CTD
PMID:22079614
NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704
G
MMP10
matrix metallopeptidase 10
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MMP10 mRNA
CTD
PMID:22079614
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
G
MMP16
matrix metallopeptidase 16
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MMP16 mRNA
CTD
PMID:20147733
NCBI chr 8:88,032,011...88,327,483
Ensembl chr 8:88,032,011...88,328,025
G
MOB4
MOB family member 4, phocein
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MOB4 mRNA
CTD
PMID:22079614
NCBI chr 2:197,515,554...197,553,699
Ensembl chr 2:197,515,571...197,553,699
G
MOCOS
molybdenum cofactor sulfurase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MOCOS mRNA
CTD
PMID:22079614
NCBI chr18:36,187,497...36,272,157
Ensembl chr18:36,187,497...36,272,157
G
MOXD1
monooxygenase DBH like 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MOXD1 mRNA
CTD
PMID:22079614
NCBI chr 6:132,296,055...132,401,475
Ensembl chr 6:132,296,055...132,401,475
G
MPP3
MAGUK p55 scaffold protein 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MPP3 mRNA
CTD
PMID:22079614
NCBI chr17:43,800,811...43,833,146
Ensembl chr17:43,800,799...43,833,170
G
MRAP
melanocortin 2 receptor accessory protein
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MRAP mRNA
CTD
PMID:22079614
NCBI chr21:32,291,813...32,314,784
Ensembl chr21:32,291,813...32,314,784
G
MRAS
muscle RAS oncogene homolog
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MRAS mRNA
CTD
PMID:22079614
NCBI chr 3:138,347,648...138,405,535
Ensembl chr 3:138,347,648...138,405,534
G
MSMO1
methylsterol monooxygenase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MSMO1 mRNA
CTD
PMID:22079614
NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164
G
MSRB3
methionine sulfoxide reductase B3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MSRB3 mRNA
CTD
PMID:22079614
NCBI chr12:65,278,683...65,466,907
Ensembl chr12:65,278,643...65,491,430
G
MTMR4
myotubularin related protein 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MTMR4 mRNA
CTD
PMID:20147733
NCBI chr17:58,489,537...58,519,047
Ensembl chr17:58,489,529...58,517,905
G
MTSS1
MTSS I-BAR domain containing 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MTSS1 mRNA
CTD
PMID:22079614
NCBI chr 8:124,550,784...124,728,473
Ensembl chr 8:124,550,784...124,728,473
G
MUC1
mucin 1, cell surface associated
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of MUC1 mRNA
CTD
PMID:16997883
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MVD
mevalonate diphosphate decarboxylase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MVD mRNA
CTD
PMID:22079614
NCBI chr16:88,651,940...88,663,091
Ensembl chr16:88,651,935...88,663,161
G
MVK
mevalonate kinase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MVK mRNA
CTD
PMID:22079614
NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125
G
MYB
MYB proto-oncogene, transcription factor
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYB mRNA
CTD
PMID:22079614
NCBI chr 6:135,181,308...135,219,172
Ensembl chr 6:135,181,308...135,219,173
G
MYC
MYC proto-oncogene, bHLH transcription factor
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MYC mRNA
CTD
PMID:22079614
NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
G
MYH7B
myosin heavy chain 7B
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYH7B mRNA
CTD
PMID:22079614
NCBI chr20:34,955,868...35,002,437
Ensembl chr20:34,955,810...35,002,437
G
MYLIP
myosin regulatory light chain interacting protein
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MYLIP mRNA
CTD
PMID:22079614
NCBI chr 6:16,129,086...16,163,887
Ensembl chr 6:16,129,086...16,148,248
G
MYOF
myoferlin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MYOF mRNA
CTD
PMID:22079614
NCBI chr10:93,306,429...93,482,334
Ensembl chr10:93,306,429...93,482,334
G
MYPN
myopalladin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of MYPN mRNA
CTD
PMID:22079614
NCBI chr10:68,087,897...68,212,017
Ensembl chr10:68,087,897...68,212,017
G
N4BP2L1
NEDD4 binding protein 2 like 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of N4BP2L1 mRNA
CTD
PMID:22079614
NCBI chr13:32,400,723...32,429,615
Ensembl chr13:32,400,723...32,428,311
G
NALF1
NALCN channel auxiliary factor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NALF1 mRNA
CTD
PMID:22079614
NCBI chr13:107,163,510...107,867,496
Ensembl chr13:107,163,510...107,867,496
G
NANOS1
nanos C2HC-type zinc finger 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NANOS1 mRNA
CTD
PMID:22079614
NCBI chr10:119,029,714...119,033,730
Ensembl chr10:119,029,714...119,033,730
G
NAP1L2
nucleosome assembly protein 1 like 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NAP1L2 mRNA
CTD
PMID:22079614
NCBI chr X:73,212,299...73,214,851
Ensembl chr X:73,212,299...73,214,851
G
NAV3
neuron navigator 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NAV3 mRNA
CTD
PMID:22079614
NCBI chr12:77,571,862...78,213,010
Ensembl chr12:77,324,641...78,213,010
G
NCF2
neutrophil cytosolic factor 2
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of NCF2 mRNA
CTD
PMID:16997883
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
G
NECTIN3
nectin cell adhesion molecule 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NECTIN3 mRNA
CTD
PMID:22079614
NCBI chr 3:111,071,816...111,194,170
Ensembl chr 3:111,070,071...111,275,563
G
NEK6
NIMA related kinase 6
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NEK6 mRNA
CTD
PMID:22079614
NCBI chr 9:124,257,606...124,353,307
Ensembl chr 9:124,257,606...124,353,307
G
NGEF
neuronal guanine nucleotide exchange factor
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NGEF mRNA
CTD
PMID:22079614
NCBI chr 2:232,878,701...233,013,256
Ensembl chr 2:232,878,701...233,013,256
G
NGF
nerve growth factor
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NGF mRNA
CTD
PMID:22079614
NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
G
NIBAN1
niban apoptosis regulator 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NIBAN1 mRNA
CTD
PMID:22079614
NCBI chr 1:184,791,032...184,974,508
Ensembl chr 1:184,790,724...184,974,508
G
NID2
nidogen 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NID2 mRNA
CTD
PMID:20147733
NCBI chr14:52,004,809...52,069,059
Ensembl chr14:52,004,809...52,069,059
G
NKX2-1
NK2 homeobox 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of NKX2-1 mRNA
CTD
PMID:16997883
NCBI chr14:36,516,397...36,520,232
Ensembl chr14:36,516,392...36,521,149
G
NLGN4Y
neuroligin 4 Y-linked
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NLGN4Y mRNA
CTD
PMID:22079614
NCBI chr Y:14,522,616...14,845,654
Ensembl chr Y:14,522,573...14,845,654
G
NMU
neuromedin U
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NMU mRNA
CTD
PMID:23423171
NCBI chr 4:55,595,231...55,636,793
Ensembl chr 4:55,595,229...55,636,698
G
NOS2
nitric oxide synthase 2
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of NOS2 mRNA]
CTD
PMID:15994020
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOTCH3
notch receptor 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NOTCH3 mRNA
CTD
PMID:20147733
NCBI chr19:15,159,038...15,200,995
Ensembl chr19:15,159,038...15,200,995
G
NR1D1
nuclear receptor subfamily 1 group D member 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NR1D1 mRNA
CTD
PMID:22079614
NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589
G
NR1D2
nuclear receptor subfamily 1 group D member 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NR1D2 mRNA
CTD
PMID:22079614
NCBI chr 3:23,945,286...23,980,617
Ensembl chr 3:23,945,286...23,980,617
G
NR1H2
nuclear receptor subfamily 1 group H member 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NR1H2 mRNA
CTD
PMID:22079614
NCBI chr19:50,376,457...50,383,388
Ensembl chr19:50,329,653...50,383,388
G
NR1H4
nuclear receptor subfamily 1 group H member 4
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Ethinyl Estradiol results in decreased expression of NR1H4 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Ethinyl Estradiol results in decreased expression of NR1H4 protein]
CTD
PMID:27743861
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
G
NR1I2
nuclear receptor subfamily 1 group I member 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR1I2 mRNA
CTD
PMID:22079614
NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
G
NR1I3
nuclear receptor subfamily 1 group I member 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR1I3 mRNA
CTD
PMID:22079614
NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
G
NR3C1
nuclear receptor subfamily 3 group C member 1
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of NR3C1 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in decreased expression of NR3C1 mRNA; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of ZNF486 mRNA]; NR3C1 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA]
CTD
PMID:23275455
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR3C2
nuclear receptor subfamily 3 group C member 2
increases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR3C2 mRNA [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of NR3C2 protein; [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of NR3C2 mRNA; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in decreased expression of GRIA1 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of DHRS3 mRNA]; NR3C2 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of FBXO32 mRNA]
CTD
PMID:22079614 PMID:23275455
NCBI chr 4:148,078,764...148,445,508
Ensembl chr 4:148,078,762...148,444,698
G
NR4A1
nuclear receptor subfamily 4 group A member 1
increases expression
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A1 protein 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A1 mRNA
CTD
PMID:21726595 PMID:22079614
NCBI chr12:52,022,832...52,059,503
Ensembl chr12:52,022,832...52,059,507
G
NR4A2
nuclear receptor subfamily 4 group A member 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A2 mRNA
CTD
PMID:22079614
NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348
G
NR4A3
nuclear receptor subfamily 4 group A member 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A3 mRNA
CTD
PMID:22079614
NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
G
NR5A1
nuclear receptor subfamily 5 group A member 1
multiple interactions
ISO
[20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] promotes the reaction [NR5A1 protein binds to MC2R promoter]; [NR5A1 protein co-treated with 20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Progesterone; [NR5A1 protein co-treated with 20-hydroxycholesterol co-treated with Tretinoin co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] affects the expression of HSD17B2 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Estradiol; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Progesterone; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased abundance of Testosterone; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP11B1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP17A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP19A1 mRNA; [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of CYP21A1 mRNA; [NR5A1 protein co-treated with LIF protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Tretinoin] results in increased abundance of Progesterone
CTD
PMID:21610156
NCBI chr 9:124,481,236...124,507,399
Ensembl chr 9:124,481,236...124,507,420
G
NRCAM
neuronal cell adhesion molecule
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NRCAM mRNA
CTD
PMID:22079614
NCBI chr 7:108,147,649...108,456,720
Ensembl chr 7:108,147,623...108,456,717
G
NRP1
neuropilin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NRP1 mRNA
CTD
PMID:22079614
NCBI chr10:33,177,493...33,334,667
Ensembl chr10:33,177,492...33,336,262
G
NTF4
neurotrophin 4
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NTF5 mRNA
CTD
PMID:22079614
NCBI chr19:49,058,284...49,065,035
Ensembl chr19:49,061,066...49,065,076
G
NUDT10
nudix hydrolase 10
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of NUDT10 mRNA
CTD
PMID:22079614
NCBI chr X:51,332,231...51,337,525
Ensembl chr X:51,332,231...51,337,525
G
NXN
nucleoredoxin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NXN mRNA
CTD
PMID:22079614
NCBI chr17:799,310...979,776
Ensembl chr17:799,310...979,776
G
OGT
O-linked N-acetylglucosamine (GlcNAc) transferase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of OGT mRNA
CTD
PMID:22079614
NCBI chr X:71,533,104...71,575,892
Ensembl chr X:71,533,087...71,575,892
G
OMG
oligodendrocyte myelin glycoprotein
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of OMG mRNA
CTD
PMID:22079614
NCBI chr17:31,294,647...31,297,239
Ensembl chr17:31,272,013...31,297,539
G
OSBP2
oxysterol binding protein 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of OSBP2 mRNA
CTD
PMID:22079614
NCBI chr22:30,693,782...30,907,813
Ensembl chr22:30,693,782...30,907,824
G
OSTF1
osteoclast stimulating factor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of OSTF1 mRNA
CTD
PMID:22079614
NCBI chr 9:75,088,514...75,147,265
Ensembl chr 9:75,088,514...75,147,265
G
OXGR1
oxoglutarate receptor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of OXGR1 mRNA
CTD
PMID:22079614
NCBI chr13:96,985,713...96,994,730
Ensembl chr13:96,985,713...96,994,730
G
P4HA3
prolyl 4-hydroxylase subunit alpha 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of P4HA3 mRNA
CTD
PMID:20147733
NCBI chr11:74,250,146...74,311,640
Ensembl chr11:74,235,801...74,311,640
G
PALM2AKAP2
PALM2 and AKAP2 fusion
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PALM2AKAP2 mRNA
CTD
PMID:22079614
NCBI chr 9:109,640,787...110,172,512
Ensembl chr 9:109,498,325...110,172,512
G
PALMD
palmdelphin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PALMD mRNA
CTD
PMID:20147733
NCBI chr 1:99,646,113...99,694,535
Ensembl chr 1:99,646,113...99,694,541
G
PAPPA
pappalysin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PAPPA mRNA
CTD
PMID:20147733
NCBI chr 9:116,153,791...116,402,321
Ensembl chr 9:116,153,791...116,402,321
G
PAPSS2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PAPSS2 mRNA
CTD
PMID:22079614
NCBI chr10:87,659,878...87,747,705
Ensembl chr10:87,659,613...87,747,705
G
PAQR5
progestin and adipoQ receptor family member 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PAQR5 mRNA
CTD
PMID:20147733
NCBI chr15:69,298,912...69,407,780
Ensembl chr15:69,298,912...69,407,780
G
PATJ
PATJ crumbs cell polarity complex component
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PATJ mRNA
CTD
PMID:22079614
NCBI chr 1:61,742,480...62,163,915
Ensembl chr 1:61,742,477...62,178,675
G
PBX4
PBX homeobox 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PBX4 mRNA
CTD
PMID:22079614
NCBI chr19:19,561,713...19,618,687
Ensembl chr19:19,561,707...19,618,693
G
PCDH20
protocadherin 20
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PCDH20 mRNA
CTD
PMID:22079614
NCBI chr13:61,409,685...61,415,849
Ensembl chr13:61,409,685...61,415,849
G
PCDHB4
protocadherin beta 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PCDHB4 mRNA
CTD
PMID:20147733
NCBI chr 5:141,121,818...141,125,623
Ensembl chr 5:141,121,818...141,125,623
G
PCSK1
proprotein convertase subtilisin/kexin type 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PCSK1 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 5:96,390,333...96,433,248
Ensembl chr 5:96,390,333...96,434,143
G
PDE1A
phosphodiesterase 1A
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PDE1A mRNA
CTD
PMID:20147733
NCBI chr 2:182,140,041...182,716,797
Ensembl chr 2:182,139,968...182,523,359
G
PDE2A
phosphodiesterase 2A
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PDE2A mRNA
CTD
PMID:22079614
NCBI chr11:72,576,141...72,674,422
Ensembl chr11:72,576,141...72,674,591
G
PDE3A
phosphodiesterase 3A
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PDE3A mRNA
CTD
PMID:12466227
NCBI chr12:20,368,537...20,688,583
Ensembl chr12:20,368,537...20,688,583
G
PDGFD
platelet derived growth factor D
decreases expression increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PDGFD mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PDGFD mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr11:103,907,189...104,164,147
Ensembl chr11:103,907,189...104,164,379
G
PDLIM4
PDZ and LIM domain 4
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of PDLIM4 mRNA
CTD
PMID:16997883
NCBI chr 5:132,257,696...132,273,454
Ensembl chr 5:132,257,696...132,273,454
G
PDZRN3
PDZ domain containing ring finger 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PDZRN3 mRNA
CTD
PMID:22079614
NCBI chr 3:73,382,431...73,624,941
Ensembl chr 3:73,382,431...73,624,941
G
PECAM1
platelet and endothelial cell adhesion molecule 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PECAM1 mRNA
CTD
PMID:16997883
NCBI chr17:64,319,415...64,390,860
Ensembl chr17:64,319,415...64,413,776
G
PEG10
paternally expressed 10
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PEG10 mRNA
CTD
PMID:20147733
NCBI chr 7:94,656,325...94,669,695
Ensembl chr 7:94,656,325...94,669,695
G
PGM5
phosphoglucomutase 5
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PGM5 mRNA
CTD
PMID:22079614
NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061
G
PGR
progesterone receptor
multiple interactions decreases expression
EXP
[8-Bromo Cyclic Adenosine Monophosphate co-treated with Progesterone co-treated with Estradiol] affects the expression of and affects the phosphorylation of PGR protein 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PGR protein
CTD
PMID:23275455
NCBI chr11:101,029,624...101,129,813
Ensembl chr11:101,029,624...101,129,813
G
PHACTR3
phosphatase and actin regulator 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PHACTR3 mRNA
CTD
PMID:22079614
NCBI chr20:59,577,509...59,847,711
Ensembl chr20:59,577,509...59,847,711
G
PHAF1
phagosome assembly factor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PHAF1 mRNA
CTD
PMID:22079614
NCBI chr16:67,109,941...67,148,544
Ensembl chr16:67,109,941...67,148,544
G
PID1
phosphotyrosine interaction domain containing 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PID1 mRNA
CTD
PMID:20147733
NCBI chr 2:229,023,973...229,271,287
Ensembl chr 2:228,850,526...229,271,287
G
PIK3R3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PIK3R3 mRNA
CTD
PMID:22079614
NCBI chr 1:46,040,140...46,174,901
Ensembl chr 1:46,040,140...46,133,036
G
PITPNC1
phosphatidylinositol transfer protein cytoplasmic 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PITPNC1 mRNA
CTD
PMID:20147733
NCBI chr17:67,377,281...67,697,256
Ensembl chr17:67,377,281...67,697,256
G
PLA2R1
phospholipase A2 receptor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PLA2R1 mRNA
CTD
PMID:22079614
NCBI chr 2:159,923,933...160,062,615
Ensembl chr 2:159,932,006...160,062,615
G
PLAT
plasminogen activator, tissue type
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PLAT mRNA
CTD
PMID:20147733
NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
G
PLCB1
phospholipase C beta 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PLCB1 mRNA
CTD
PMID:20147733
NCBI chr20:8,132,266...8,884,900
Ensembl chr20:8,077,251...8,968,360
G
PLD1
phospholipase D1
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of and results in increased activity of PLD1 protein; PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of IGFBP1 mRNA]; PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA]
CTD
PMID:17065600
NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950
G
PMEPA1
prostate transmembrane protein, androgen induced 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PMEPA1 mRNA
CTD
PMID:22079614
NCBI chr20:57,648,396...57,711,472
Ensembl chr20:57,648,392...57,711,536
G
PON3
paraoxonase 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PON3 mRNA
CTD
PMID:22079614
NCBI chr 7:95,359,872...95,396,375
Ensembl chr 7:95,359,872...95,396,375
G
POU3F1
POU class 3 homeobox 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of POU3F1 mRNA
CTD
PMID:22079614
NCBI chr 1:38,043,829...38,046,793
Ensembl chr 1:38,043,829...38,046,793
G
PPARA
peroxisome proliferator activated receptor alpha
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARA mRNA
CTD
PMID:22079614
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
G
PPARG
peroxisome proliferator activated receptor gamma
decreases expression multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]
CTD
PMID:15994020
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PPFIBP1
PPFIA binding protein 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PPFIBP1 mRNA
CTD
PMID:22079614
NCBI chr12:27,524,206...27,695,564
Ensembl chr12:27,523,431...27,695,564
G
PPM1H
protein phosphatase, Mg2+/Mn2+ dependent 1H
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPM1H mRNA
CTD
PMID:22079614
NCBI chr12:62,643,994...62,935,150
Ensembl chr12:62,643,994...62,935,150
G
PPP1R3C
protein phosphatase 1 regulatory subunit 3C
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PPP1R3C mRNA
CTD
PMID:20147733
NCBI chr10:91,628,442...91,633,071
Ensembl chr10:91,628,442...91,633,071
G
PRKACB
protein kinase cAMP-activated catalytic subunit beta
multiple interactions
EXP
[PRKACB protein mutant form results in increased susceptibility to 8-Bromo Cyclic Adenosine Monophosphate analog] results in decreased stability of [PRKACB protein mutant form binds to PRKAR1A protein]
CTD
PMID:29669941
NCBI chr 1:84,078,079...84,238,498
Ensembl chr 1:84,078,062...84,238,498
G
PRKAR1A
protein kinase cAMP-dependent type I regulatory subunit alpha
multiple interactions
EXP
[PRKACB protein mutant form results in increased susceptibility to 8-Bromo Cyclic Adenosine Monophosphate analog] results in decreased stability of [PRKACB protein mutant form binds to PRKAR1A protein]
CTD
PMID:29669941
NCBI chr17:68,413,623...68,551,316
Ensembl chr17:68,511,780...68,551,319
G
PRKAR2B
protein kinase cAMP-dependent type II regulatory subunit beta
increases expression multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRKAR2B mRNA [monobutyryl cyclic AMP co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of PRKAR2B protein
CTD
PMID:18467523 PMID:22079614
NCBI chr 7:107,044,705...107,161,811
Ensembl chr 7:107,044,705...107,161,811
G
PRKCA
protein kinase C alpha
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRKCA mRNA
CTD
PMID:22079614
NCBI chr17:66,302,613...66,810,743
Ensembl chr17:66,302,613...66,810,743
G
PRL
prolactin
multiple interactions increases expression decreases expression increases secretion
EXP ISO
1-Butanol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA]; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Dexamethasone] results in increased expression of PRL mRNA; [8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein; EZH2 mutant form inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate co-treated with Medroxyprogesterone Acetate] results in increased expression of PRL mRNA]; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased secretion of PRL protein]; PLD1 protein affects the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA]; Progesterone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA]; Tobacco Smoke Pollution inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA] 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PRL protein 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRL mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRL protein 8-Bromo Cyclic Adenosine Monophosphate results in increased secretion of PRL protein
CTD
PMID:15774544 PMID:16709600 PMID:17065600 PMID:18815356 PMID:20147733 PMID:20955787 PMID:21273127 PMID:21467749 PMID:21903722 PMID:23275455 More...
NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
G
PRMT7
protein arginine methyltransferase 7
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRMT7 mRNA
CTD
PMID:22079614
NCBI chr16:68,311,019...68,360,870
Ensembl chr16:68,310,951...68,360,852
G
PRSS23
serine protease 23
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PRSS23 mRNA
CTD
PMID:22079614
NCBI chr11:86,791,071...86,952,910
Ensembl chr11:86,791,059...86,952,910
G
PSAT1
phosphoserine aminotransferase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PSAT1 mRNA
CTD
PMID:22079614
NCBI chr 9:78,297,125...78,330,093
Ensembl chr 9:78,297,125...78,330,093
G
PSG4
pregnancy specific beta-1-glycoprotein 4
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PSG4 mRNA
CTD
PMID:20147733
NCBI chr19:43,192,702...43,205,638
Ensembl chr19:43,192,702...43,207,299
G
PSG7
pregnancy specific beta-1-glycoprotein 7
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PSG7 mRNA
CTD
PMID:20147733
NCBI chr19:42,924,132...42,937,207
Ensembl chr19:42,924,132...42,937,207
G
PTGDR2
prostaglandin D2 receptor 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PTGDR2 mRNA
CTD
PMID:22079614
NCBI chr11:60,850,933...60,855,950
Ensembl chr11:60,850,933...60,855,950
G
PTGS1
prostaglandin-endoperoxide synthase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTGS1 mRNA
CTD
PMID:22079614
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [IL1B protein results in increased expression of PTGS2 protein]; [PTGS2 co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of VEGFA
CTD
PMID:11112151 PMID:12821125
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTH
parathyroid hormone
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTH mRNA
CTD
PMID:22079614
NCBI chr11:13,492,054...13,496,181
Ensembl chr11:13,492,054...13,496,181
G
PTHLH
parathyroid hormone like hormone
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTHLH mRNA
CTD
PMID:20147733
NCBI chr12:27,958,084...27,972,733
Ensembl chr12:27,958,084...27,972,733
G
PTK2
protein tyrosine kinase 2
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [HU 211 results in increased phosphorylation of PTK2 protein]
CTD
PMID:12163181
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
G
PTP4A1
protein tyrosine phosphatase 4A1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTP4A1 mRNA
CTD
PMID:22079614
NCBI chr 6:63,516,440...63,583,588
Ensembl chr 6:63,521,746...63,583,588
G
PTPRE
protein tyrosine phosphatase receptor type E
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTPRE mRNA
CTD
PMID:22079614
NCBI chr10:127,907,103...128,085,855
Ensembl chr10:127,907,103...128,085,855
G
PTPRF
protein tyrosine phosphatase receptor type F
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PTPRF mRNA
CTD
PMID:22079614
NCBI chr 1:43,522,051...43,623,666
Ensembl chr 1:43,525,187...43,623,666
G
PTPRZ1
protein tyrosine phosphatase receptor type Z1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PTPRZ1 mRNA
CTD
PMID:22079614
NCBI chr 7:121,873,161...122,062,036
Ensembl chr 7:121,873,089...122,062,036
G
PTS
6-pyruvoyltetrahydropterin synthase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PTS mRNA
CTD
PMID:22079614
NCBI chr11:112,226,428...112,233,973
Ensembl chr11:112,226,367...112,269,955
G
PXYLP1
2-phosphoxylose phosphatase 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PXYLP1 mRNA
CTD
PMID:22079614
NCBI chr 3:141,231,825...141,294,924
Ensembl chr 3:141,228,726...141,367,753
G
PYGL
glycogen phosphorylase L
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PYGL mRNA
CTD
PMID:22079614
NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483
G
PZP
PZP alpha-2-macroglobulin like
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PZP mRNA
CTD
PMID:22079614
NCBI chr12:9,136,472...9,208,395
Ensembl chr12:9,148,840...9,208,395
G
RAB25
RAB25, member RAS oncogene family
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RAB25 mRNA
CTD
PMID:22079614
NCBI chr 1:156,061,160...156,070,504
Ensembl chr 1:156,061,160...156,070,504
G
RAB27B
RAB27B, member RAS oncogene family
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RAB27B mRNA
CTD
PMID:20147733
NCBI chr18:54,717,857...54,895,516
Ensembl chr18:54,717,860...54,895,516
G
RABGAP1
RAB GTPase activating protein 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RABGAP1 mRNA
CTD
PMID:22079614
NCBI chr 9:122,931,671...123,104,866
Ensembl chr 9:122,940,833...123,104,866
G
RAN
RAN, member RAS oncogene family
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RAN mRNA
CTD
PMID:22079614
NCBI chr12:130,872,066...130,877,678
Ensembl chr12:130,872,037...130,877,678
G
RAP1A
RAP1A, member of RAS oncogene family
increases activity
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased activity of RAP1A protein
CTD
PMID:10908723
NCBI chr 1:111,542,009...111,716,691
Ensembl chr 1:111,542,218...111,716,691
G
RAP1B
RAP1B, member of RAS oncogene family
increases activity
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased activity of RAP1B protein
CTD
PMID:10908723
NCBI chr12:68,610,899...68,671,901
Ensembl chr12:68,610,855...68,671,901
G
RARG
retinoic acid receptor gamma
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RARG mRNA
CTD
PMID:22079614
NCBI chr12:53,210,569...53,232,209
Ensembl chr12:53,210,567...53,232,980
G
RARRES2
retinoic acid receptor responder 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RARRES2 mRNA
CTD
PMID:22079614
NCBI chr 7:150,338,329...150,341,629
Ensembl chr 7:150,338,317...150,341,662
G
RASD1
ras related dexamethasone induced 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RASD1 mRNA
CTD
PMID:20147733
NCBI chr17:17,494,437...17,496,395
Ensembl chr17:17,494,437...17,496,395
G
RASIP1
Ras interacting protein 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RASIP1 mRNA
CTD
PMID:22079614
NCBI chr19:48,720,585...48,740,610
Ensembl chr19:48,720,585...48,740,610
G
RASSF5
Ras association domain family member 5
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RASSF5 mRNA
CTD
PMID:22079614
NCBI chr 1:206,507,531...206,589,448
Ensembl chr 1:206,507,531...206,589,448
G
RASSF6
Ras association domain family member 6
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RASSF6 mRNA
CTD
PMID:22079614
NCBI chr 4:73,571,550...73,620,631
Ensembl chr 4:73,571,550...73,620,631
G
RBMS3
RNA binding motif single stranded interacting protein 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RBMS3 mRNA
CTD
PMID:22079614
NCBI chr 3:29,281,071...30,010,395
Ensembl chr 3:28,574,791...30,010,391
G
RBP1
retinol binding protein 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RBP1 mRNA
CTD
PMID:22079614
NCBI chr 3:139,517,438...139,539,742
Ensembl chr 3:139,517,434...139,539,829
G
REPS2
RALBP1 associated Eps domain containing 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of REPS2 mRNA
CTD
PMID:22079614
NCBI chr X:16,946,658...17,196,655
Ensembl chr X:16,946,658...17,153,272
G
RFX6
regulatory factor X6
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RFX6 mRNA
CTD
PMID:22079614
NCBI chr 6:116,877,242...116,932,161
Ensembl chr 6:116,877,212...116,932,161
G
RGS16
regulator of G protein signaling 16
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RGS16 mRNA
CTD
PMID:22079614
NCBI chr 1:182,598,623...182,604,389
Ensembl chr 1:182,598,623...182,604,389
G
RHBG
Rh family B glycoprotein
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RHBG mRNA
CTD
PMID:22079614
NCBI chr 1:156,369,211...156,385,219
Ensembl chr 1:156,369,211...156,385,219
G
RHOB
ras homolog family member B
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RHOB mRNA
CTD
PMID:22079614
NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
G
RHOBTB1
Rho related BTB domain containing 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RHOBTB1 mRNA
CTD
PMID:22079614
NCBI chr10:60,860,860...61,001,967
Ensembl chr10:60,869,438...61,001,440
G
RHOU
ras homolog family member U
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RHOU mRNA
CTD
PMID:22079614
NCBI chr 1:228,644,647...228,746,669
Ensembl chr 1:228,735,479...228,746,664
G
RILP
Rab interacting lysosomal protein
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RILP mRNA
CTD
PMID:22079614
NCBI chr17:1,646,150...1,649,866
Ensembl chr17:1,646,145...1,649,866
G
RIN3
Ras and Rab interactor 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIN3 mRNA
CTD
PMID:22079614
NCBI chr14:92,513,781...92,688,994
Ensembl chr14:92,513,781...92,688,994
G
RIPK3
receptor interacting serine/threonine kinase 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIPK3 mRNA
CTD
PMID:22079614
NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
G
RIPOR2
RHO family interacting cell polarization regulator 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RIPOR2 mRNA
CTD
PMID:20147733
NCBI chr 6:24,804,284...25,042,168
Ensembl chr 6:24,804,282...25,042,170
G
RNASE8
ribonuclease A family member 8
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RNASE8 mRNA
CTD
PMID:22079614
NCBI chr14:21,057,822...21,058,455
Ensembl chr14:21,057,822...21,058,455
G
RNF144B
ring finger protein 144B
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RNF144B mRNA
CTD
PMID:22079614
NCBI chr 6:18,387,350...18,468,870
Ensembl chr 6:18,387,350...18,468,870
G
ROBO2
roundabout guidance receptor 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ROBO2 mRNA
CTD
PMID:22079614
NCBI chr 3:75,906,675...77,649,964
Ensembl chr 3:75,906,695...77,649,964
G
ROR1
receptor tyrosine kinase like orphan receptor 1
multiple interactions decreases expression
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of ROR1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ROR1 mRNA
CTD
PMID:16997883 PMID:22079614
NCBI chr 1:63,774,017...64,181,498
Ensembl chr 1:63,774,017...64,181,498
G
RORA
RAR related orphan receptor A
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RORA mRNA
CTD
PMID:22079614
NCBI chr15:60,488,284...61,229,302
Ensembl chr15:60,488,284...61,229,302
G
RORB
RAR related orphan receptor B
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RORB mRNA
CTD
PMID:22079614
NCBI chr 9:74,497,335...74,693,177
Ensembl chr 9:74,497,335...74,693,177
G
RPH3AL
rabphilin 3A like (without C2 domains)
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RPH3AL mRNA
CTD
PMID:22079614
NCBI chr17:212,389...352,807
Ensembl chr17:212,389...386,254
G
RRM2
ribonucleotide reductase regulatory subunit M2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RRM2 mRNA
CTD
PMID:22079614
NCBI chr 2:10,122,568...10,211,010
Ensembl chr 2:10,120,698...10,211,725
G
RSPO1
R-spondin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RSPO1 mRNA
CTD
PMID:22079614
NCBI chr 1:37,611,350...37,634,892
Ensembl chr 1:37,611,350...37,634,892
G
RUNX1T1
RUNX1 partner transcriptional co-repressor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RUNX1T1 mRNA
CTD
PMID:22079614
NCBI chr 8:91,954,967...92,103,385
Ensembl chr 8:91,954,972...92,103,385
G
RXRB
retinoid X receptor beta
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RXRB mRNA
CTD
PMID:22079614
NCBI chr 6:33,193,588...33,200,853
Ensembl chr 6:33,193,588...33,200,665
G
RXRG
retinoid X receptor gamma
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of RXRG mRNA
CTD
PMID:22079614
NCBI chr 1:165,400,922...165,445,126
Ensembl chr 1:165,400,922...165,445,355
G
RYR3
ryanodine receptor 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of RYR3 mRNA
CTD
PMID:22079614
NCBI chr15:33,310,967...33,866,102
Ensembl chr15:33,310,962...33,866,121
G
SAMD3
sterile alpha motif domain containing 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SAMD3 mRNA
CTD
PMID:22079614
NCBI chr 6:130,142,752...130,365,868
Ensembl chr 6:130,144,315...130,365,425
G
SC5D
sterol-C5-desaturase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SC5D mRNA
CTD
PMID:22079614
NCBI chr11:121,292,771...121,313,410
Ensembl chr11:121,292,681...121,313,410
G
SCARB1
scavenger receptor class B member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCARB1 mRNA
CTD
PMID:22079614
NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
G
SCG2
secretogranin II
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCG2 mRNA
CTD
PMID:22079614
NCBI chr 2:223,596,940...223,602,361
Ensembl chr 2:223,596,940...223,602,361
G
SCGB1C1
secretoglobin family 1C member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCGB1C1 mRNA
CTD
PMID:22079614
NCBI chr11:188,050...194,575
Ensembl chr11:193,078...194,575
G
SCRG1
stimulator of chondrogenesis 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SCRG1 mRNA
CTD
PMID:22079614
NCBI chr 4:173,384,701...173,519,144
Ensembl chr 4:173,384,701...173,406,380
G
SERPINA11
serpin family A member 11
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SERPINA11 mRNA
CTD
PMID:22079614
NCBI chr14:94,442,464...94,452,800
Ensembl chr14:94,442,464...94,452,800
G
SERPINE1
serpin family E member 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of SERPINE1 mRNA
CTD
PMID:16997883
NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
G
SERPINI1
serpin family I member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SERPINI1 mRNA
CTD
PMID:22079614
NCBI chr 3:167,735,721...167,825,569
Ensembl chr 3:167,735,243...167,825,569
G
SESN3
sestrin 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SESN3 mRNA
CTD
PMID:20147733
NCBI chr11:95,165,513...95,232,475
Ensembl chr11:95,165,513...95,232,541
G
SF1
splicing factor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SF1 mRNA
CTD
PMID:22079614
NCBI chr11:64,764,606...64,778,542
Ensembl chr11:64,764,606...64,778,786
G
SFRP1
secreted frizzled related protein 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SFRP1 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 8:41,261,962...41,309,473
Ensembl chr 8:41,261,962...41,309,473
G
SFTPA2
surfactant protein A2
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SFTPA2 mRNA
CTD
PMID:16997883
NCBI chr10:79,555,852...79,560,407
Ensembl chr10:79,555,852...79,560,407
G
SFTPB
surfactant protein B
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SFTPB mRNA
CTD
PMID:16997883
NCBI chr 2:85,657,307...85,668,741
Ensembl chr 2:85,657,314...85,668,741
G
SFTPC
surfactant protein C
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SFTPC mRNA
CTD
PMID:16997883
NCBI chr 8:22,157,383...22,164,479
Ensembl chr 8:22,156,913...22,164,479
G
SGCD
sarcoglycan delta
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGCD mRNA
CTD
PMID:20147733
NCBI chr 5:155,727,832...156,767,788
Ensembl chr 5:155,870,344...156,767,788
G
SGK1
serum/glucocorticoid regulated kinase 1
increases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGK1 mRNA Estradiol inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGK1 mRNA]; Genistein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGK1 mRNA]
CTD
PMID:21056929
NCBI chr 6:134,169,256...134,318,112
Ensembl chr 6:134,169,248...134,318,112
G
SGMS1
sphingomyelin synthase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SGMS1 mRNA
CTD
PMID:22079614
NCBI chr10:50,305,600...50,625,184
Ensembl chr10:50,305,586...50,625,163
G
SH3BP5
SH3 domain binding protein 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SH3BP5 mRNA
CTD
PMID:22079614
NCBI chr 3:15,254,353...15,341,380
Ensembl chr 3:15,254,353...15,341,368
G
SIRT1
sirtuin 1
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SIRT1 protein
CTD
PMID:16709600
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
G
SIRT3
sirtuin 3
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SIRT3 mRNA
CTD
PMID:23166782
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
G
SLC16A6
solute carrier family 16 member 6
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC16A6 mRNA
CTD
PMID:20147733
NCBI chr17:68,267,026...68,291,479
Ensembl chr17:68,267,026...68,291,267
G
SLC17A5
solute carrier family 17 member 5
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC17A5 mRNA
CTD
PMID:22079614
NCBI chr 6:73,593,379...73,653,992
Ensembl chr 6:73,593,379...73,653,992
G
SLC22A11
solute carrier family 22 member 11
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC22A11 mRNA
CTD
PMID:22079614
NCBI chr11:64,555,941...64,572,875
Ensembl chr11:64,555,690...64,572,875
G
SLC25A36
solute carrier family 25 member 36
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC25A36 mRNA
CTD
PMID:16997883
NCBI chr 3:140,941,836...140,980,995
Ensembl chr 3:140,941,830...140,980,995
G
SLC26A4
solute carrier family 26 member 4
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC26A4 protein
CTD
PMID:22811483
NCBI chr 7:107,660,828...107,717,809
Ensembl chr 7:107,660,828...107,717,809
G
SLC26A7
solute carrier family 26 member 7
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC26A7 mRNA
CTD
PMID:22079614
NCBI chr 8:91,209,496...91,398,155
Ensembl chr 8:91,209,494...91,398,155
G
SLC27A2
solute carrier family 27 member 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC27A2 mRNA
CTD
PMID:22079614
NCBI chr15:50,182,196...50,236,385
Ensembl chr15:50,182,196...50,236,385
G
SLC27A4
solute carrier family 27 member 4
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC27A4 mRNA
CTD
PMID:22079614
NCBI chr 9:128,340,527...128,361,470
Ensembl chr 9:128,340,527...128,361,470
G
SLC2A12
solute carrier family 2 member 12
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC2A12 mRNA
CTD
PMID:20147733
NCBI chr 6:133,987,581...134,052,624
Ensembl chr 6:133,987,581...134,052,624
G
SLC39A8
solute carrier family 39 member 8
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC39A8 mRNA
CTD
PMID:16997883
NCBI chr 4:102,251,041...102,345,482
Ensembl chr 4:102,251,080...102,431,258
G
SLC3A2
solute carrier family 3 member 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC3A2 mRNA
CTD
PMID:22079614
NCBI chr11:62,856,109...62,888,860
Ensembl chr11:62,856,004...62,888,880
G
SLC51A
solute carrier family 51 member A
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC51A mRNA
CTD
PMID:22079614
NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178
G
SLC5A12
solute carrier family 5 member 12
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC5A12 mRNA
CTD
PMID:22079614
NCBI chr11:26,667,020...26,723,389
Ensembl chr11:26,667,020...26,723,427
G
SLC5A7
solute carrier family 5 member 7
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC5A7 mRNA
CTD
PMID:22079614
NCBI chr 2:107,986,524...108,013,994
Ensembl chr 2:107,986,523...108,013,994
G
SLC6A14
solute carrier family 6 member 14
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLC6A14 mRNA
CTD
PMID:16997883
NCBI chr X:116,436,606...116,461,458
Ensembl chr X:116,436,606...116,461,458
G
SLC6A9
solute carrier family 6 member 9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC6A9 mRNA
CTD
PMID:20147733
NCBI chr 1:43,996,483...44,031,462
Ensembl chr 1:43,991,500...44,031,467
G
SLC7A1
solute carrier family 7 member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC7A1 mRNA
CTD
PMID:22079614
NCBI chr13:29,509,414...29,595,688
Ensembl chr13:29,509,414...29,595,688
G
SLC7A11
solute carrier family 7 member 11
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC7A11 mRNA
CTD
PMID:22079614
NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349
G
SLC9A1
solute carrier family 9 member A1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC9A1 mRNA
CTD
PMID:22079614
NCBI chr 1:27,098,809...27,155,125
Ensembl chr 1:27,098,809...27,166,981
G
SLCO4C1
solute carrier organic anion transporter family member 4C1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SLCO4C1 mRNA
CTD
PMID:16997883
NCBI chr 5:102,233,986...102,296,284
Ensembl chr 5:102,233,986...102,296,284
G
SMOC1
SPARC related modular calcium binding 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SMOC1 mRNA
CTD
PMID:20147733
NCBI chr14:69,879,416...70,032,366
Ensembl chr14:69,854,131...70,032,366
G
SMOX
spermine oxidase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SMOX mRNA
CTD
PMID:20147733
NCBI chr20:4,148,828...4,187,727
Ensembl chr20:4,120,980...4,187,747
G
SNCA
synuclein alpha
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SNCA mRNA
CTD
PMID:22079614
NCBI chr 4:89,724,099...89,838,304
Ensembl chr 4:89,700,345...89,838,315
G
SOAT1
sterol O-acyltransferase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SOAT1 mRNA
CTD
PMID:22079614
NCBI chr 1:179,293,797...179,358,680
Ensembl chr 1:179,293,714...179,358,680
G
SOCS3
suppressor of cytokine signaling 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SOCS3 mRNA
CTD
PMID:22079614
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
G
SOD1
superoxide dismutase 1
multiple interactions increases expression
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD1 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SOD1 mRNA
CTD
PMID:16709600 PMID:22079614
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
G
SOD2
superoxide dismutase 2
multiple interactions
EXP
[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA; [Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 protein; FOXO1 protein affects the reaction [[Medroxyprogesterone Acetate co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of SOD2 mRNA]
CTD
PMID:16709600
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SOX5
SRY-box transcription factor 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SOX5 mRNA
CTD
PMID:22079614
NCBI chr12:23,529,504...24,562,650
Ensembl chr12:23,529,504...24,562,544
G
SPATA9
spermatogenesis associated 9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPATA9 mRNA
CTD
PMID:22079614
NCBI chr 5:95,652,181...95,732,102
Ensembl chr 5:95,652,181...95,698,711
G
SPINK5
serine peptidase inhibitor Kazal type 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPINK5 mRNA
CTD
PMID:22079614
NCBI chr 5:148,063,980...148,137,382
Ensembl chr 5:148,025,683...148,137,382
G
SPOCK2
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPOCK2 mRNA
CTD
PMID:22079614
NCBI chr10:72,059,034...72,089,032
Ensembl chr10:72,059,034...72,089,032
G
SPON1
spondin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPON1 mRNA
CTD
PMID:20147733
NCBI chr11:13,962,723...14,268,133
Ensembl chr11:13,962,723...14,268,133
G
SPP1
secreted phosphoprotein 1
multiple interactions decreases expression
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]; Dinitrochlorobenzene inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; KT 5823 inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in increased secretion of SPP1 protein]] 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SPP1 mRNA
CTD
PMID:20453393 PMID:22079614
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPRR1A
small proline rich protein 1A
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRR1A mRNA
CTD
PMID:22079614
NCBI chr 1:152,984,081...152,985,814
Ensembl chr 1:152,984,081...152,985,814
G
SPRR1B
small proline rich protein 1B
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRR1B mRNA
CTD
PMID:22079614
NCBI chr 1:153,031,203...153,032,900
Ensembl chr 1:153,031,203...153,032,900
G
SPRR3
small proline rich protein 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRR3 mRNA
CTD
PMID:22079614
NCBI chr 1:153,001,749...153,003,856
Ensembl chr 1:153,001,747...153,003,856
G
SPRY2
sprouty RTK signaling antagonist 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SPRY2 mRNA
CTD
PMID:22079614
NCBI chr13:80,335,976...80,341,126
Ensembl chr13:80,335,976...80,341,126
G
SQLE
squalene epoxidase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SQLE mRNA
CTD
PMID:22079614
NCBI chr 8:124,998,505...125,022,283
Ensembl chr 8:124,998,497...125,022,283
G
SRD5A1
steroid 5 alpha-reductase 1
increases expression
ISO
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SRD5A1 mRNA
CTD
PMID:24014645
NCBI chr 5:6,633,440...6,674,386
Ensembl chr 5:6,633,290...6,676,539
G
SREBF1
sterol regulatory element binding transcription factor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SREBF1 mRNA
CTD
PMID:22079614
NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
G
ST3GAL1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ST3GAL1 mRNA
CTD
PMID:22079614
NCBI chr 8:133,454,848...133,571,887
Ensembl chr 8:133,454,848...133,571,926
G
ST3GAL6
ST3 beta-galactoside alpha-2,3-sialyltransferase 6
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ST3GAL6 mRNA
CTD
PMID:22079614
NCBI chr 3:98,732,262...98,795,852
Ensembl chr 3:98,732,236...98,821,201
G
STAR
steroidogenic acute regulatory protein
increases expression multiple interactions
ISO EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; bifenthrin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; LEPR protein affects the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; Mitotane inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; SB 203580 inhibits the reaction [LEP protein inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]]; T-2 Toxin inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA] 2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; 8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [sodium arsenite results in increased expression of STAR mRNA]; 8-Bromo Cyclic Adenosine Monophosphate promotes the reaction [sodium arsenite results in increased expression of STAR protein]; Anisomycin promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Dantrolene inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Hydrocarbons, Chlorinated inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; Ryanodine inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; SB 203580 promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; SB 203580 promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; sodium arsenite promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; sodium arsenite promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]]; Triiodothyronine inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Valproic Acid inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]; Valproic Acid inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR protein]
CTD
PMID:15713539 PMID:16254025 PMID:18815356 PMID:19849856 PMID:20732403 PMID:21726595 PMID:22079614 PMID:22546480 PMID:23183170 PMID:24014645 PMID:24328340 PMID:24740604 PMID:28859905 PMID:30951242 PMID:34896276 More...
NCBI chr 8:38,142,700...38,150,952
Ensembl chr 8:38,142,700...38,150,992
G
STARD3
StAR related lipid transfer domain containing 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STARD3 mRNA
CTD
PMID:22079614
NCBI chr17:39,637,144...39,664,201
Ensembl chr17:39,637,090...39,664,201
G
STC1
stanniocalcin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STC1 mRNA
CTD
PMID:20147733
NCBI chr 8:23,841,929...23,854,806
Ensembl chr 8:23,841,929...23,854,806
G
STC2
stanniocalcin 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STC2 mRNA
CTD
PMID:22079614
NCBI chr 5:173,314,723...173,328,414
Ensembl chr 5:173,314,723...173,328,447
G
STK17B
serine/threonine kinase 17b
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STK17B mRNA
CTD
PMID:22079614
NCBI chr 2:196,133,583...196,176,483
Ensembl chr 2:196,133,583...196,176,503
G
STRA6
signaling receptor and transporter of retinol STRA6
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STRA6 mRNA
CTD
PMID:22079614
NCBI chr15:74,179,466...74,212,259
Ensembl chr15:74,179,466...74,212,267
G
STX2
syntaxin 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STX2 mRNA
CTD
PMID:22079614
NCBI chr12:130,789,600...130,839,250
Ensembl chr12:130,789,600...130,839,254
G
STX3
syntaxin 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of STX3 mRNA
CTD
PMID:22079614
NCBI chr11:59,754,188...59,805,878
Ensembl chr11:59,713,456...59,805,882
G
SULT2A1
sulfotransferase family 2A member 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SULT2A1 mRNA
CTD
PMID:22079614
NCBI chr19:47,870,467...47,886,315
Ensembl chr19:47,870,467...47,886,315
G
SULT4A1
sulfotransferase family 4A member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SULT4A1 mRNA
CTD
PMID:22079614
NCBI chr22:43,824,509...43,862,513
Ensembl chr22:43,824,509...43,862,513
G
SV2C
synaptic vesicle glycoprotein 2C
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SV2C mRNA
CTD
PMID:22079614
NCBI chr 5:75,847,464...76,353,939
Ensembl chr 5:76,083,383...76,353,939
G
SVIL
supervillin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SVIL mRNA
CTD
PMID:20147733
NCBI chr10:29,457,338...29,736,936
Ensembl chr10:29,457,338...29,736,959
G
SYNE1
spectrin repeat containing nuclear envelope protein 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SYNE1 mRNA
CTD
PMID:22079614
NCBI chr 6:152,121,687...152,637,362
Ensembl chr 6:152,121,687...152,637,801
G
SYT12
synaptotagmin 12
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SYT12 mRNA
CTD
PMID:22079614
NCBI chr11:67,006,771...67,050,863
Ensembl chr11:67,006,778...67,050,863
G
SYT9
synaptotagmin 9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SYT9 mRNA
CTD
PMID:22079614
NCBI chr11:7,238,778...7,469,043
Ensembl chr11:7,238,778...7,469,043
G
TAC1
tachykinin precursor 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TAC1 mRNA
CTD
PMID:22079614
NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
G
TACC2
transforming acidic coiled-coil containing protein 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TACC2 mRNA
CTD
PMID:22079614
NCBI chr10:121,989,163...122,254,542
Ensembl chr10:121,989,163...122,254,545
G
TAFA5
TAFA chemokine like family member 5
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TAFA5 mRNA
CTD
PMID:22079614
NCBI chr22:48,489,553...48,751,932
Ensembl chr22:48,489,553...48,850,912
G
TBC1D2
TBC1 domain family member 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TBC1D2 mRNA
CTD
PMID:20147733
NCBI chr 9:98,198,998...98,255,649
Ensembl chr 9:98,199,011...98,255,649
G
TCF21
transcription factor 21
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TCF21 mRNA
CTD
PMID:20147733
NCBI chr 6:133,889,113...133,895,537
Ensembl chr 6:133,889,113...133,895,553
G
TEF
TEF transcription factor, PAR bZIP family member
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TEF mRNA
CTD
PMID:22079614
NCBI chr22:41,367,455...41,399,326
Ensembl chr22:41,367,333...41,399,326
G
TENT5A
terminal nucleotidyltransferase 5A
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TENT5A mRNA
CTD
PMID:22079614
NCBI chr 6:81,745,730...81,752,681
Ensembl chr 6:81,491,439...81,752,774
G
TESK1
testis associated actin remodelling kinase 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TESK1 mRNA
CTD
PMID:22079614
NCBI chr 9:35,605,262...35,610,033
Ensembl chr 9:35,605,262...35,610,041
G
TFPI2
tissue factor pathway inhibitor 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TFPI2 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753
G
TGFB1
transforming growth factor beta 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB1 mRNA
CTD
PMID:16997883
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
TGFB1I1
transforming growth factor beta 1 induced transcript 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TGFB1I1 mRNA
CTD
PMID:22079614
NCBI chr16:31,472,152...31,477,960
Ensembl chr16:31,471,585...31,477,960
G
TGFB2
transforming growth factor beta 2
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB2 mRNA
CTD
PMID:16997883
NCBI chr 1:218,345,336...218,444,619
Ensembl chr 1:218,345,336...218,444,619
G
TGFB3
transforming growth factor beta 3
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TGFB3 mRNA
CTD
PMID:16997883
NCBI chr14:75,958,097...75,983,011
Ensembl chr14:75,958,097...75,983,011
G
TGFBR2
transforming growth factor beta receptor 2
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TGFBR2 mRNA
CTD
PMID:22079614
NCBI chr 3:30,606,356...30,694,142
Ensembl chr 3:30,606,478...30,694,249
G
THRA
thyroid hormone receptor alpha
multiple interactions
ISO
THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP11A1 mRNA]]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CYP17A1 mRNA]]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD3B1 mRNA]]; THRA mutant form inhibits the reaction [2,2',4,4'-tetrahydroxybenzophenone promotes the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of STAR mRNA]]
CTD
PMID:21726595
NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
G
TIPARP
TCDD inducible poly(ADP-ribose) polymerase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TIPARP mRNA
CTD
PMID:22079614
NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770
G
TLCD3A
TLC domain containing 3A
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TLCD3A mRNA
CTD
PMID:22079614
NCBI chr17:732,596...742,968
Ensembl chr17:732,412...742,968
G
TMC5
transmembrane channel like 5
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of TMC5 mRNA
CTD
PMID:16997883
NCBI chr16:19,410,539...19,499,113
Ensembl chr16:19,410,496...19,499,113
G
TMOD1
tropomodulin 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TMOD1 mRNA
CTD
PMID:20147733
NCBI chr 9:97,501,180...97,601,743
Ensembl chr 9:97,501,180...97,601,743
G
TMX4
thioredoxin related transmembrane protein 4
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TMX4 mRNA
CTD
PMID:20147733
NCBI chr20:7,977,346...8,019,761
Ensembl chr20:7,977,346...8,019,805
G
TNC
tenascin C
multiple interactions increases expression
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNC mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNC mRNA
CTD
PMID:16997883 PMID:20147733
NCBI chr 9:115,019,575...115,118,157
Ensembl chr 9:115,019,575...115,118,207
G
TNF
tumor necrosis factor
multiple interactions
EXP ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [TNF protein results in increased secretion of CCL2 protein]] 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of CCL5 mRNA]; 8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]
CTD
PMID:10495789 PMID:11230753 PMID:21803157
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP3
TNF alpha induced protein 3
multiple interactions increases expression
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNFAIP3 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNFAIP3 mRNA
CTD
PMID:16997883 PMID:22079614
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TNFRSF10A
TNF receptor superfamily member 10a
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNFRSF10A mRNA
CTD
PMID:22079614
NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
G
TNFRSF12A
TNF receptor superfamily member 12A
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNFRSF12A mRNA
CTD
PMID:22079614
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
G
TNFRSF19
TNF receptor superfamily member 19
decreases expression increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TNFRSF19 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNFRSF19 mRNA
CTD
PMID:20147733 PMID:22079614
NCBI chr13:23,570,412...23,676,093
Ensembl chr13:23,570,370...23,676,104
G
TNFSF4
TNF superfamily member 4
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TNFSF4 mRNA
CTD
PMID:16997883
NCBI chr 1:173,172,870...173,450,733
Ensembl chr 1:173,162,645...173,477,583
G
TNNT2
troponin T2, cardiac type
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TNNT2 mRNA
CTD
PMID:22079614
NCBI chr 1:201,359,014...201,377,680
Ensembl chr 1:201,359,008...201,377,764
G
TP53
tumor protein p53
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53; 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TP53 protein
CTD
PMID:10642304 PMID:11802967
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,546
G
TPH2
tryptophan hydroxylase 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TPH2 mRNA
CTD
PMID:22079614
NCBI chr12:71,938,845...72,032,440
Ensembl chr12:71,938,845...72,186,618
G
TPM1
tropomyosin 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TPM1 mRNA
CTD
PMID:16997883
NCBI chr15:63,042,747...63,071,915
Ensembl chr15:63,042,620...63,071,915
G
TPMT
thiopurine S-methyltransferase
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TPMT mRNA
CTD
PMID:22079614
NCBI chr 6:18,128,311...18,155,169
Ensembl chr 6:18,128,311...18,155,077
G
TRBV21-1
T cell receptor beta variable 21-1 (pseudogene)
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of TRBV21-1 mRNA
CTD
PMID:16997883
NCBI chr 7:142,636,924...142,637,384
Ensembl chr 7:142,636,924...142,637,384
G
TRIB3
tribbles pseudokinase 3
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRIB3 mRNA
CTD
PMID:22079614
NCBI chr20:380,760...397,559
Ensembl chr20:362,835...397,559
G
TRIM2
tripartite motif containing 2
multiple interactions increases expression
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of TRIM2 mRNA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRIM2 mRNA
CTD
PMID:16997883 PMID:20147733
NCBI chr 4:153,152,163...153,339,317
Ensembl chr 4:153,152,163...153,339,319
G
TRIM24
tripartite motif containing 24
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRIM24 mRNA
CTD
PMID:22079614
NCBI chr 7:138,460,259...138,589,996
Ensembl chr 7:138,460,259...138,589,996
G
TRIP10
thyroid hormone receptor interactor 10
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TRIP10 mRNA
CTD
PMID:22079614
NCBI chr19:6,739,680...6,751,530
Ensembl chr19:6,737,925...6,751,530
G
TRPA1
transient receptor potential cation channel subfamily A member 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TRPA1 mRNA
CTD
PMID:22079614
NCBI chr 8:72,021,250...72,090,010
Ensembl chr 8:72,019,917...72,075,584
G
TSHZ2
teashirt zinc finger homeobox 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TSHZ2 mRNA
CTD
PMID:20147733
NCBI chr20:52,972,358...53,495,330
Ensembl chr20:52,972,358...53,495,330
G
TTC9
tetratricopeptide repeat domain 9
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TTC9 mRNA
CTD
PMID:22079614
NCBI chr14:70,641,916...70,675,366
Ensembl chr14:70,641,916...70,675,366
G
TXLNGY
taxilin gamma Y-linked (pseudogene)
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of TXLNGY mRNA
CTD
PMID:22079614
NCBI chr Y:19,567,358...19,607,170
Ensembl chr Y:19,567,382...19,604,120 Ensembl chr Y:19,567,382...19,604,120
G
TXN
thioredoxin
multiple interactions
ISO
8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [Glucose results in decreased expression of TXN1 protein]
CTD
PMID:20453393
NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
G
UGT2B11
UDP glucuronosyltransferase family 2 member B11
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of UGT2B11 mRNA
CTD
PMID:22079614
NCBI chr 4:69,199,951...69,224,984
Ensembl chr 4:69,199,951...69,214,748
G
UGT2B17
UDP glucuronosyltransferase family 2 member B17
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UGT2B17 mRNA
CTD
PMID:22079614
NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
G
UGT2B7
UDP glucuronosyltransferase family 2 member B7
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of UGT2B7 mRNA
CTD
PMID:22079614
NCBI chr 4:69,051,375...69,112,987
Ensembl chr 4:69,051,363...69,112,987
G
UNC5B
unc-5 netrin receptor B
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of UNC5B mRNA
CTD
PMID:22079614
NCBI chr10:71,212,570...71,302,864
Ensembl chr10:71,212,570...71,302,864
G
USHBP1
USH1 protein network component harmonin binding protein 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of USHBP1 mRNA
CTD
PMID:22079614
NCBI chr19:17,249,171...17,264,745
Ensembl chr19:17,249,171...17,282,786
G
UTS2
urotensin 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of UTS2 mRNA
CTD
PMID:22079614
NCBI chr 1:7,847,612...7,913,249
Ensembl chr 1:7,843,083...7,853,512
G
UTY
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of UTY mRNA
CTD
PMID:22079614
NCBI chr Y:13,233,895...13,480,670
Ensembl chr Y:13,234,577...13,480,673
G
VDR
vitamin D receptor
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VDR mRNA
CTD
PMID:22079614
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
VEGFA
vascular endothelial growth factor A
multiple interactions increases expression
EXP ISO
[PTGS2 co-treated with 8-Bromo Cyclic Adenosine Monophosphate] results in increased expression of VEGFA 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VEGFA mRNA
CTD
PMID:10788502 PMID:12821125 PMID:20147733
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VEGFC
vascular endothelial growth factor C
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VEGFC mRNA
CTD
PMID:22079614
NCBI chr 4:176,683,538...176,792,922
Ensembl chr 4:176,683,538...176,792,922
G
VGF
VGF nerve growth factor inducible
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VGF mRNA
CTD
PMID:22079614
NCBI chr 7:101,162,509...101,169,952
Ensembl chr 7:101,162,509...101,165,569
G
VGLL3
vestigial like family member 3
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VGLL3 mRNA
CTD
PMID:20147733
NCBI chr 3:86,937,973...86,991,149
Ensembl chr 3:86,876,388...86,991,149
G
VIPR1
vasoactive intestinal peptide receptor 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VIPR1 mRNA
CTD
PMID:22079614
NCBI chr 3:42,489,299...42,537,568
Ensembl chr 3:42,489,299...42,537,573
G
VLDLR
very low density lipoprotein receptor
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of VLDLR mRNA
CTD
PMID:22079614
NCBI chr 9:2,621,787...2,660,056
Ensembl chr 9:2,621,182...2,660,056
G
VMO1
vitelline membrane outer layer 1 homolog
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of VMO1 mRNA
CTD
PMID:20147733
NCBI chr17:4,785,285...4,786,364
Ensembl chr17:4,785,285...4,786,433
G
WDR17
WD repeat domain 17
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of WDR17 mRNA
CTD
PMID:22079614
NCBI chr 4:176,065,841...176,182,815
Ensembl chr 4:176,065,841...176,182,818
G
WHRN
whirlin
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of WHRN mRNA
CTD
PMID:22079614
NCBI chr 9:114,402,080...114,505,473
Ensembl chr 9:114,402,080...114,505,473
G
WIF1
WNT inhibitory factor 1
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of WIF1 mRNA
CTD
PMID:16997883
NCBI chr12:65,050,626...65,121,305
Ensembl chr12:65,050,626...65,121,305
G
WNT4
Wnt family member 4
decreases expression multiple interactions
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of WNT4 mRNA [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA; NR3C1 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA]
CTD
PMID:22079614 PMID:23275455
NCBI chr 1:22,117,313...22,143,097
Ensembl chr 1:22,117,313...22,143,969
G
WNT5B
Wnt family member 5B
multiple interactions
EXP
[Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT5B mRNA
CTD
PMID:16997883
NCBI chr12:1,617,056...1,647,212
Ensembl chr12:1,529,891...1,647,212
G
XBP1
X-box binding protein 1
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of XBP1 mRNA
CTD
PMID:22079614
NCBI chr22:28,794,560...28,800,569
Ensembl chr22:28,794,555...28,800,597
G
ZBTB12
zinc finger and BTB domain containing 12
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZBTB12 mRNA
CTD
PMID:22079614
NCBI chr 6:31,899,613...31,902,086
Ensembl chr 6:31,899,613...31,902,086
G
ZBTB18
zinc finger and BTB domain containing 18
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ZBTB18 mRNA
CTD
PMID:22079614
NCBI chr 1:244,048,491...244,057,476
Ensembl chr 1:244,048,547...244,057,476
G
ZBTB32
zinc finger and BTB domain containing 32
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ZBTB32 mRNA
CTD
PMID:22079614
NCBI chr19:35,704,558...35,717,038
Ensembl chr19:35,704,558...35,717,038
G
ZFP36L1
ZFP36 ring finger protein like 1
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ZFP36L1 mRNA
CTD
PMID:22079614
NCBI chr14:68,787,655...68,796,243
Ensembl chr14:68,787,660...68,796,253
G
ZFP36L2
ZFP36 ring finger protein like 2
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZFP36L2 mRNA
CTD
PMID:22079614
NCBI chr 2:43,222,402...43,226,606
Ensembl chr 2:43,222,402...43,226,606
G
ZNF436
zinc finger protein 436
decreases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ZNF436 mRNA
CTD
PMID:22079614
NCBI chr 1:23,359,448...23,369,836
Ensembl chr 1:23,359,448...23,369,836
G
ZNF454
zinc finger protein 454
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZNF454 mRNA
CTD
PMID:22079614
NCBI chr 5:178,941,198...178,990,028
Ensembl chr 5:178,941,191...178,966,433
G
ZNF486
zinc finger protein 486
multiple interactions
EXP
[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of ZNF486 mRNA; NR3C1 protein inhibits the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of ZNF486 mRNA]
CTD
PMID:23275455
NCBI chr19:20,167,214...20,200,488
Ensembl chr19:20,167,214...20,200,488
G
ZNF847P
zinc finger protein 847, pseudogene
increases expression
EXP
8-Bromo Cyclic Adenosine Monophosphate results in increased expression of ZNF847P mRNA
CTD
PMID:22079614
NCBI chr 1:227,697,032...227,697,707
Ensembl chr 1:227,696,892...227,706,699
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all